RGUHS MD Pharmacology Question Papers, 2006–2026
This page lists all 1,245 RGUHS MD Pharmacology theory questions in the PharmaNotes Pro question index: 30 exam sessions between 2006 and 2026. They are grouped by topic, newest first, and 429 of them link to the PharmaNotes Pro chapter on their topic.
The chapter library files some questions under more than one textbook chapter, so it lists these 1,245 questions 1,271 times; each appears once here.
Questions are reproduced from RGUHS MD Pharmacology theory papers. Answers are PharmaNotes Pro chapters written from the standard textbooks, not official university answers.
The 10 most-repeated RGUHS topics
Ranked by the number of the 30 sessions with at least one question on the topic. Only topics with a PharmaNotes Pro chapter are ranked. Past repetition describes these papers; it does not predict the next exam.
- Pharmacovigilance
- Newer Oral Antidiabetics & SGLT2 Inhibitors
- Pharmacogenomics & Personalized Medicine
- General Principles of Antimicrobial Therapy
- Newer Antidepressants
- Phases of Clinical Trials in Drug Development
- Receptor Concept & Drug-Receptor Interaction
- Calcineurin Inhibitors & Immunosuppressants
- Haematopoietic Growth Factors & Agents
- Pharmacoeconomics
All 1,245 questions, by topic
Topics follow textbook order. A heading that links opens the PharmaNotes Pro chapter for that topic; questions not yet assigned to a chapter are listed under the textbook chapter they are filed in.
Gene Therapy
- Jun 2020 · Paper 1 · Q2 · 10 marksGene therapy
- May 2019 · Paper 4 · Q8 · 10 marksGene therapy
- May 2010 · Paper 1 · Q8 · 10 marksChimeraplasty
- Oct 2009 · Paper 1 · Q3 · 10 marksAntisense oligonucleotides
- Oct 2009 · Paper 1 · Q8 · 10 marksRibozymes
- Oct 2009 · Paper 3 · Q4 · 10 marksGene therapy
- Oct 2008 · Paper 4 · Q3 · 10 marksGene therapy
- Apr 2008 · Paper 1 · Q8 · 10 marksGene therapy
Novel Drug Delivery Systems (NDDS)
- Nov 2021 · Paper 1 · Q7 · 10 marksNewer drug delivery systems
- Jun 2020 · Paper 1 · Q7 · 10 marksNovel methods of Drug delivery
- Nov 2019 · Paper 1 · Q7 · 10 marksNewer drug delivery systems
- Jun 2016 · Paper 1 · Q5 · 10 marksNewer drug delivery systems
- May 2011 · Paper 1 · Q5 · 10 marksNewer drug delivery systems
- May 2011 · Paper 4 · Q8 · 10 marksRecent advances in drug delivery system for Diabetes Mellitus.
- Oct 2008 · Paper 1 · Q7 · 10 marksNewer drug delivery systems
Orphan Drugs
- May 2018 · Paper 1 · Q4 · 10 marksOrphan drugs
- Nov 2017 · Paper 1 · Q9 · 10 marksOrphan drugs
- Jun 2016 · Paper 1 · Q3 · 10 marksOrphan drugs
- Sep 2006 · Paper 1 · Q6 · 10 marksOrphan drugs
Animal Toxicity Studies
- Jun 2024 · Paper 4 · Q2 · 10 marksDiscuss about toxicity testing in animals for new drugs
- May 2010 · Paper 1 · Q5 · 10 marksCurrent status of LD 50 test
- Apr 2006 · Paper 1 · Q4 · 10 marksCarcinogenicity
Drug Enantiomers and Chirality
- Sep 2007 · Paper 1 · Q7 · 10 marksSterioisomers
- Apr 2006 · Paper 1 · Q5 · 10 marksEnantiomers
Drug Repurposing
- May 2019 · Paper 4 · Q3 · 10 marksNewer uses of old drugs
- Oct 2009 · Paper 4 · Q1 · 20 marksNew uses for old drugs. Discuss the novel therapeutic options
Reverse Pharmacology
- Jun 2016 · Paper 4 · Q5 · 10 marksStatus of herbal drug research in India
- May 2011 · Paper 1 · Q6 · 10 marksComplementary and alternative medicine
Biosimilars
- May 2022 · Paper 4 · Q6 · 10 marksBiosimilars
Essential Medicines & Rational Drug Use
- Apr 2007 · Paper 4 · Q6 · 10 marksTherapeutic jungle
Drug Discovery: From Medicinal Plants to Computer-Aided Drug Design
- Mar 2026 · Paper 4 · Q8 · 10 marksEpigenetics in drug discovery with examples.
- Sep 2025 · Paper 4 · Q1 · 10 marksClinical pharmacology of Orphan drugs
- May 2025 · Paper 1 · Q3 · 10 marksTargeted drug delivery systems
- May 2025 · Paper 1 · Q8 · 10 marksDrug enantiomers
- May 2025 · Paper 4 · Q5 · 10 marksReverse pharmacology
- May 2025 · Paper 4 · Q6 · 10 marksComputer aided drug designing
- Dec 2023 · Paper 1 · Q3 · 10 marksNanoparticles
- Dec 2023 · Paper 1 · Q7 · 10 marksReverse pharmacology
- Dec 2023 · Paper 4 · Q9 · 10 marksNew drug delivery system
- Jul 2023 · Paper 1 · Q3 · 10 marksNanoparticles
- Jul 2023 · Paper 1 · Q7 · 10 marksReverse pharmacology
- Jul 2023 · Paper 4 · Q9 · 10 marksNew drug delivery system
- Nov 2022 · Paper 4 · Q3 · 10 marksWrite five examples of toxin based drugs approved for treatment by USFDA.
- Nov 2022 · Paper 4 · Q7 · 10 marksHerbal Drug interactions with examples.
- May 2022 · Paper 1 · Q2 · 10 marksSAR and Drug design
- May 2022 · Paper 4 · Q7 · 10 marksNanomedicine
- Nov 2021 · Paper 1 · Q6 · 10 marksDrug Enantiomers
- Jul 2021 · Paper 1 · Q1 · 10 marksTargeted drug delivery system
- Nov 2020 · Paper 1 · Q2 · 10 marksDescribe the new drug delivery systems.
- May 2019 · Paper 4 · Q10 · 10 marksTargeted drug delivery
- Nov 2017 · Paper 1 · Q10 · 10 marksTargeted drug delivery system
- Nov 2016 · Paper 4 · Q3 · 10 marksGene therapy for inherited conditions
- May 2011 · Paper 3 · Q5 · 10 marksTherapeutic applications of Nano technology
- May 2010 · Paper 1 · Q3 · 10 marksComputer aided drug design
- May 2009 · Paper 1 · Q6 · 10 marksStereochemistry and therapeutic relevance
- May 2009 · Paper 1 · Q8 · 10 marksDiscuss the uses of drugs as diagnostic agents
- May 2009 · Paper 4 · Q6 · 10 marksOrphan Drug
- Sep 2007 · Paper 1 · Q3 · 10 marksTransdermal drug delivery system
- Sep 2007 · Paper 4 · Q1 · 20 marksDescribe current status of gene therapy.
- Apr 2007 · Paper 1 · Q4 · 10 marksTargeted drug delivery system
- Apr 2007 · Paper 1 · Q7 · 10 marksChiral compounds
- Apr 2006 · Paper 4 · Q2 · 20 marksDescribe the general concept of structure activity relationship.
Pharmacoeconomics
- Nov 2021 · Paper 4 · Q4 · 10 marksCost effective analysis
- Jul 2021 · Paper 4 · Q6 · 10 marksPharmacoeconomics
- Jun 2020 · Paper 4 · Q6 · 10 marksPharmacoeconomics
- Nov 2018 · Paper 4 · Q6 · 10 marksCost - effective analysis
- May 2011 · Paper 4 · Q6 · 10 marksPharmaco economics
- May 2009 · Paper 1 · Q6 · 10 marksPharmaco economics
- Apr 2008 · Paper 1 · Q5 · 10 marksPharmacoeconomics
- Sep 2007 · Paper 4 · Q4 · 10 marksPharmacoeconomics
Therapeutic Drug Monitoring
- Jul 2021 · Paper 1 · Q9 · 10 marksTherapeutic drug monitoring
- Jun 2020 · Paper 1 · Q4 · 10 marksTherapeutic Drug Monitoring
- May 2019 · Paper 1 · Q5 · 10 marksTherapeutic drug monitoring
- Nov 2017 · Paper 4 · Q4 · 10 marksTherapeutic drug monitoring
- Nov 2016 · Paper 1 · Q7 · 10 marksTherapeutic drug monitoring
- Nov 2016 · Paper 4 · Q4 · 10 marksTherapeutic drug monitoring
- May 2009 · Paper 4 · Q3 · 10 marksTherapeutic Drug Monitoring
- Apr 2007 · Paper 1 · Q5 · 10 marksTherapeutic drug monitoring
Chronopharmacology & Chronotherapeutics
- Mar 2026 · Paper 1 · Q5 · 10 marksChronopharmacology and its significance
- Dec 2023 · Paper 4 · Q4 · 10 marksChronopharmacology
- Jul 2023 · Paper 4 · Q4 · 10 marksChronopharmacology
- Jun 2020 · Paper 4 · Q4 · 10 marksChronopharmacology and its significance
- Oct 2010 · Paper 4 · Q7 · 10 marksChronopharmacology
- Apr 2007 · Paper 4 · Q5 · 10 marksChronopharmacology
- Apr 2006 · Paper 4 · Q3 · 10 marksChronopharmacology
Pharmacometrics
- Dec 2023 · Paper 4 · Q6 · 10 marksPharmacometrics
- Jul 2023 · Paper 4 · Q6 · 10 marksPharmacometrics
- May 2011 · Paper 1 · Q3 · 10 marksPharmacometrics
- Oct 2010 · Paper 1 · Q3 · 10 marksPharmacometrics
Bioavailability and Bioequivalence Studies
- Jul 2021 · Paper 4 · Q4 · 10 marksBio equivalence
- Oct 2009 · Paper 4 · Q6 · 10 marksBio availability and Bio equivalence studies
Drug Dosage Principles & Individualisation
- Nov 2016 · Paper 1 · Q6 · 10 marksInfluence of age on dosage of drugs
- May 2011 · Paper 4 · Q2 · 20 marksDiscuss the factors modifying drug action in disease conditions
Pharmacokinetics: ADME
- Mar 2026 · Paper 1 · Q7 · 10 marksMechanisms of drug excretion
- May 2009 · Paper 1 · Q1 · 20 marksDiscuss how the pharmacokinetic variables affect pharcodynamics
Pharmacokinetics: ADME
- Mar 2026 · Paper 1 · Q6 · 10 marksSpecial drug delivery systems
- Mar 2026 · Paper 4 · Q3 · 10 marksRenal elimination of drugs and its clinical significance.
- Mar 2026 · Paper 4 · Q7 · 10 marksTherapeutic drug monitoring - methods, its application and limitations.
- Sep 2025 · Paper 1 · Q3 · 10 marksChronokinetics
- Sep 2025 · Paper 4 · Q5 · 10 marksDiscuss the principles, methods, advantages and limitations of therapeutic drug monitoring
- May 2025 · Paper 4 · Q10 · 10 marksApplications of Area under the curve
- Jun 2024 · Paper 1 · Q6 · 10 marksEntero-hepatic recirculation and its role in therapeutics
- Jun 2024 · Paper 1 · Q8 · 10 marksPlasma protein binding and its clinical significance
- Dec 2023 · Paper 1 · Q10 · 10 marksPrimary pharmacokinetic parameters
- Jul 2023 · Paper 1 · Q10 · 10 marksPrimary pharmacokinetic parameters
- Nov 2022 · Paper 1 · Q3 · 10 marksDrug reservoirs
- Nov 2022 · Paper 1 · Q4 · 10 marksBioequivalence
- May 2022 · Paper 1 · Q7 · 10 marksMichle's menten kinetics
- Nov 2021 · Paper 1 · Q5 · 10 marksHalf life of a drug and its applications
- Jul 2021 · Paper 4 · Q5 · 10 marksArea under curve
- Nov 2020 · Paper 1 · Q1 · 10 marksElimination of drugs from the body and termination of drug effect.
- Jun 2020 · Paper 1 · Q3 · 10 marksMulti compartment model of volume distribution
- Nov 2019 · Paper 4 · Q3 · 10 marksDiscuss the principles of therapeutic drug monitoring
- Nov 2019 · Paper 4 · Q7 · 10 marksSteady state plasma concentration of drugs
- May 2019 · Paper 1 · Q4 · 10 marksZero order kinetics
- Nov 2018 · Paper 1 · Q8 · 10 marksClinical importance of plasma protein binding
- May 2018 · Paper 1 · Q5 · 10 marksKinetics of clearance of drugs
- May 2018 · Paper 1 · Q10 · 10 marksDrug distribution
- Nov 2017 · Paper 1 · Q1 · 10 marksTransfer of drugs across the biological membrane
- Nov 2017 · Paper 1 · Q5 · 10 marksPlasma Half-Life
- Nov 2016 · Paper 1 · Q2 · 20 marksWrite an essay on factors influencing drug absorption.
- Nov 2016 · Paper 1 · Q5 · 10 marksTransdermal administration of drugs
- Jun 2016 · Paper 1 · Q1 · 20 marksWrite in detail the physicochemical factors influencing the transfer of drugs across cell membrane.
- May 2011 · Paper 1 · Q1 · 20 marksDiscuss the factors affecting the bioavailability of a drug. Add a note on the drug usage in humans
- May 2011 · Paper 1 · Q4 · 10 marksDrug delivery systems.
- May 2011 · Paper 1 · Q5 · 10 marksTherapeutic Window phenomenon.
- May 2011 · Paper 1 · Q8 · 10 marksRenal excretion of drugs
- May 2011 · Paper 4 · Q3 · 10 marksApparent volume of distribution
- Oct 2010 · Paper 4 · Q6 · 10 marksDrug dosage
- May 2010 · Paper 1 · Q2 · 20 marksDiscuss the mechanisms in hepato-bihary and renal exertion of drugs with related drug-drug interactions
- May 2010 · Paper 4 · Q3 · 10 marksTherapeutic window
- May 2010 · Paper 4 · Q4 · 10 marksRole of pharmacokinetics in the safety evaluation and approval of a new drug
- May 2010 · Paper 4 · Q7 · 10 marksSteady state concentration
- Oct 2009 · Paper 1 · Q2 · 20 marksDescribe the various routes of drug excretion. Give suitable examples
- Oct 2009 · Paper 1 · Q7 · 10 marksBio availability
- Oct 2009 · Paper 1 · Q7 · 10 marksSpecial drug delivery systems
- Oct 2009 · Paper 4 · Q3 · 10 marksHepatic extraction ratio
- Oct 2009 · Paper 4 · Q4 · 10 marksDrug targeting
- Oct 2009 · Paper 4 · Q5 · 10 marksSteady state plasma concentration
- May 2009 · Paper 1 · Q5 · 10 marksPulmonary absorption
- May 2009 · Paper 1 · Q7 · 10 marksApparent volume of distribution
- Oct 2008 · Paper 1 · Q2 · 20 marksWrite an essay on drug absorption elucidating factors which affect it
- Oct 2008 · Paper 1 · Q5 · 10 marksDrug clearance
- Oct 2008 · Paper 4 · Q4 · 10 marksBio availability of drugs
- Apr 2008 · Paper 1 · Q7 · 10 marksPlasma protein binding of drugs
- Apr 2008 · Paper 4 · Q6 · 10 marksPhysiological determinants of pharmacokinetic parameters
- Sep 2007 · Paper 1 · Q4 · 10 marksRenal elimination of drugs
- Apr 2007 · Paper 1 · Q8 · 10 marksZero order kinetics
- Sep 2006 · Paper 1 · Q1 · 20 marksDescribe the physicochemical factors that are involved in the transfer of drugs across membranes. Explain the factors affecting the bioavailability of drugs.
- Sep 2006 · Paper 1 · Q2 · 20 marksDiscuss the pharmacodynamic and pharmacokinetic drug interactions.
- Sep 2006 · Paper 4 · Q2 · 20 marksDiscuss in detail therapeutic drug monitoring.
- Apr 2006 · Paper 1 · Q2 · 20 marksDescribe bioavailability of the drug. Discuss its clinical importance
Receptor Concept & Drug-Receptor Interaction
- Mar 2026 · Paper 1 · Q1 · 10 marksMolecular targets of drug action
- Jun 2024 · Paper 1 · Q2 · 10 marksTabulate Ion channels as drug targets with examples
- May 2011 · Paper 1 · Q6 · 10 marksG-protein coupled receptors.
- Oct 2010 · Paper 1 · Q4 · 10 marksIon channels and drug action.
- May 2010 · Paper 1 · Q7 · 10 marksIon channels
- Apr 2008 · Paper 1 · Q1 · 20 marksDiscuss the mechanisms of drug action and the relationship between drug concentration and effect
- Sep 2007 · Paper 1 · Q1 · 20 marksDescribe pharmacology of ion channels. Discuss various drugs modifying potassium channels
- Apr 2007 · Paper 4 · Q7 · 10 marksPharmacodynamic variability
Pharmacodynamics: Molecular Mechanisms of Drug Action
- Mar 2026 · Paper 1 · Q3 · 10 marksDrug Synergisms and Antagonisms
- Mar 2026 · Paper 1 · Q4 · 10 marksMeasures of drug safety
- Sep 2025 · Paper 1 · Q4 · 10 marksDescribe the types of receptor antagonism with suitable diagram
- May 2025 · Paper 1 · Q1 · 10 marksDrug - receptor interactions
- Jun 2024 · Paper 1 · Q3 · 10 marksEstimation of pA2 values
- Dec 2023 · Paper 1 · Q5 · 10 marksAuto receptors
- Dec 2023 · Paper 1 · Q9 · 10 marksDose-response relationship
- Jul 2023 · Paper 1 · Q5 · 10 marksAuto receptors
- Jul 2023 · Paper 1 · Q9 · 10 marksDose-response relationship
- Nov 2022 · Paper 1 · Q1 · 10 marksReceptor mediated mechanism of drug action
- Nov 2022 · Paper 1 · Q8 · 10 marksBeneficial drug interactions
- Nov 2022 · Paper 1 · Q10 · 10 marksDrug Antagonism
- Nov 2021 · Paper 1 · Q1 · 10 marksDiscuss the Drug Interactions with suitable examples.
- Nov 2021 · Paper 1 · Q2 · 10 marksDiscuss the receptor concept of drug action.
- Jul 2021 · Paper 1 · Q3 · 10 marksSecond messengers
- Nov 2020 · Paper 1 · Q3 · 10 marksInverse agonist
- Nov 2020 · Paper 1 · Q9 · 10 marksTherapeutic window
- Jun 2020 · Paper 1 · Q8 · 10 marksDrug Antagonism
- Nov 2019 · Paper 1 · Q2 · 10 marksDiscuss the receptor concept of drug action.
- Nov 2018 · Paper 1 · Q6 · 10 marksTherapeutic applications of drug antagonism
- Nov 2017 · Paper 1 · Q2 · 10 marksDescribe the receptor concept of drug action.
- Nov 2017 · Paper 1 · Q4 · 10 marksTherapeutic index
- Nov 2017 · Paper 4 · Q7 · 10 marksEnzymes in therapy
- Nov 2016 · Paper 1 · Q8 · 10 marksDrug synergism
- Jun 2016 · Paper 1 · Q4 · 10 marksDrugs receptors in pharmacodynamics
- May 2011 · Paper 1 · Q3 · 10 marksReceptor regulation
- Oct 2010 · Paper 1 · Q2 · 20 marksDiscuss the important theories of drug-receptor interactions and outline the common signal transduction mechanisms for drug effects.
- Oct 2010 · Paper 1 · Q6 · 10 marksNuclear receptors
- May 2010 · Paper 1 · Q2 · 20 marksDiscuss the signal transduction pathways and drug actions.
- Oct 2009 · Paper 1 · Q2 · 20 marksDiscuss the pharmacology of pre-synaptic receptors.
- May 2009 · Paper 1 · Q1 · 20 marksDescribe the structural and functional families of physiological receptors, with suitable examples
- May 2009 · Paper 1 · Q2 · 20 marksReceptor concept of drug action
- May 2009 · Paper 1 · Q4 · 10 marksSecond messenger system
- Oct 2008 · Paper 1 · Q1 · 20 marksWrite an essay on drug receptors and its importance
- Apr 2008 · Paper 1 · Q2 · 20 marksDiscuss the role of organic Placebo, Route, Tolerance, Synergism and Antagonism in modifying drug action
- Sep 2006 · Paper 3 · Q3 · 10 marksHormone receptors
- Apr 2006 · Paper 1 · Q1 · 20 marksDescribe role of receptors in drug action
Membrane Transporters and Drug Response
- Sep 2025 · Paper 4 · Q4 · 10 marksMembrane transporters in drug response
- Dec 2023 · Paper 1 · Q2 · 10 marksDrug Transport system
- Jul 2023 · Paper 1 · Q2 · 10 marksDrug Transport system
- Nov 2022 · Paper 1 · Q9 · 10 marksRole of transport proteins in drug passage
- May 2022 · Paper 1 · Q8 · 10 marksVectorial transport
- May 2019 · Paper 1 · Q10 · 10 marksABC transporters
- Nov 2018 · Paper 1 · Q2 · 10 marksDrug transporters and their implications in therapeutics.
- Oct 2010 · Paper 1 · Q7 · 10 marksCarrier mediated transport
- May 2010 · Paper 1 · Q7 · 10 marksP-Glycoprotein
- Oct 2009 · Paper 1 · Q4 · 10 marksP glycoprotein
Microdosing and Phase-0 Studies
- May 2018 · Paper 1 · Q9 · 10 marksPhase zero clinical trial
- May 2018 · Paper 4 · Q8 · 10 marksPhase zero clinical trial
Drug Metabolism
- Mar 2026 · Paper 1 · Q9 · 10 marksExplain microsomal enzyme induction and its consequences
- Sep 2025 · Paper 1 · Q2 · 10 marksEnzyme inhibition and its consequences
- May 2025 · Paper 1 · Q2 · 10 marksProdrugs and their clinical implications
- Jun 2024 · Paper 4 · Q1 · 10 marksDiscuss about drug interactions
- May 2022 · Paper 1 · Q9 · 10 marksMixed function oxidases.
- Nov 2021 · Paper 1 · Q8 · 10 marksPhases of Biotransformation with suitable examples
- Nov 2020 · Paper 1 · Q10 · 10 marksCYP 450 system (Cytochrome P-450 system)
- Jun 2020 · Paper 1 · Q1 · 10 marksBiotransformation and clinical relevance of enzyme inhibition
- Jun 2020 · Paper 1 · Q5 · 10 marksXenobiotics
- Nov 2019 · Paper 1 · Q8 · 10 marksMicrosomal enzymes
- May 2019 · Paper 1 · Q1 · 10 marksRole of cytochrome P-450-3A4 in drug metabolism.
- May 2019 · Paper 1 · Q9 · 10 marksProdrugs
- May 2011 · Paper 1 · Q1 · 20 marksDiscuss in detail about drug interactions
- May 2010 · Paper 1 · Q6 · 10 marksPro drugs
- Oct 2009 · Paper 1 · Q1 · 20 marksDiscuss the current concept on Cytochrome P 450 enzymes.
- May 2009 · Paper 1 · Q2 · 20 marksDescribe the super family of cytochrome P450 enzymes and its relevant drug metabolism pathway. Give suitable examples
- Apr 2008 · Paper 4 · Q8 · 10 marksPro drugs
- Apr 2007 · Paper 1 · Q1 · 20 marksDescribe various pathways of drug metabolism and factors modifying it
- Apr 2006 · Paper 1 · Q3 · 10 marksNon-renal drug elimination
The GI Microbiome and Drug Response
- Nov 2022 · Paper 2 · Q10 · 10 marksProbiotics and Prebiotics
- May 2018 · Paper 4 · Q5 · 10 marksProbiotics
- Nov 2017 · Paper 2 · Q10 · 10 marksProbiotics
Pharmacogenomics & Personalized Medicine
- Nov 2019 · Paper 1 · Q4 · 10 marksPharmacogenetics
- May 2019 · Paper 1 · Q3 · 10 marksIdiosyncrasy
- Nov 2018 · Paper 1 · Q5 · 10 marksPharmacogenomics
- Nov 2018 · Paper 4 · Q10 · 10 marksProteomics
- May 2018 · Paper 4 · Q1 · 10 marksGenetically mediated adverse reactions to drugs.
- May 2010 · Paper 1 · Q5 · 10 marksPharmacogenomics
- Apr 2008 · Paper 4 · Q3 · 10 marksPharmacogenetics
- Sep 2007 · Paper 1 · Q6 · 10 marksIdiosyncrasy
- Sep 2007 · Paper 4 · Q8 · 10 marksPharmacogenetics
- Sep 2006 · Paper 1 · Q4 · 10 marksPharmacogenetics
- Sep 2006 · Paper 1 · Q5 · 10 marksGenetic variability of receptors
- Apr 2006 · Paper 4 · Q8 · 10 marksPharmacogenomics
Pharmacogenetics and Pharmacogenomics
- May 2025 · Paper 4 · Q2 · 10 marksPrecision Medicine
- May 2022 · Paper 1 · Q1 · 10 marksPharmacogenetics and pharmacogenomics
- Nov 2017 · Paper 1 · Q8 · 10 marksGenetic polymorphism in drug metabolism
- May 2010 · Paper 1 · Q1 · 20 marksDiscuss the molecular mechanism of genetic polymorphism of drug metabolism.
Pharmacovigilance
- Dec 2023 · Paper 4 · Q3 · 10 marksPost marketing surveillance
- Jul 2023 · Paper 4 · Q3 · 10 marksPost marketing surveillance
- May 2022 · Paper 4 · Q2 · 10 marksPharmacovigilance
- Nov 2021 · Paper 4 · Q2 · 10 marksPost marketing surveillance
- Nov 2019 · Paper 4 · Q8 · 10 marksPharmocovigilance
- Nov 2017 · Paper 4 · Q9 · 10 marksPharmacovigilance
- May 2011 · Paper 1 · Q2 · 20 marksDescribe the adverse effects associated with the drug usage in humans
- Oct 2010 · Paper 4 · Q3 · 10 marksPharmacovigilance
- May 2010 · Paper 4 · Q8 · 10 marksPharmacovigilance
- May 2009 · Paper 4 · Q7 · 10 marksPharmacovigilence
- Apr 2008 · Paper 1 · Q4 · 10 marks'Iatrogenic' drug reactions
- Apr 2008 · Paper 4 · Q5 · 10 marksPost marketing surveillance
- Sep 2007 · Paper 4 · Q6 · 10 marksPost-marketing surveillance
- Sep 2006 · Paper 1 · Q3 · 10 marksDrug induced agranulocytosis
- Sep 2006 · Paper 4 · Q6 · 10 marksPharmacovigilance
Pharmacoepidemiology
- Dec 2023 · Paper 4 · Q7 · 10 marksPharmacoepidemiology
- Jul 2023 · Paper 4 · Q7 · 10 marksPharmacoepidemiology
- Jul 2021 · Paper 1 · Q4 · 10 marksPharmacoepidemiology
- May 2019 · Paper 4 · Q1 · 10 marksPharmacoepidemiology.
- Oct 2009 · Paper 4 · Q8 · 10 marksPharmaco epedemiology
- Apr 2008 · Paper 4 · Q4 · 10 marksPharmacoepidemiology
Drug Schedules under the Drugs & Cosmetics Act
- Mar 2026 · Paper 1 · Q2 · 10 marksDrug Schedules
- Oct 2010 · Paper 4 · Q6 · 10 marksSchedule Y
- May 2009 · Paper 4 · Q5 · 10 marksSchedule Y
Off-Label Use & Medication Errors
- Dec 2023 · Paper 4 · Q10 · 10 marksOff - label uses of drugs
- Jul 2023 · Paper 4 · Q10 · 10 marksOff - label uses of drugs
Postmarketing Drug Safety
- Mar 2026 · Paper 1 · Q8 · 10 marksMedication errors
- Jun 2024 · Paper 1 · Q1 · 10 marksDefine Over The Counter drugs; brief on regulations in India and add a note on ''Switch Process"
- Jun 2024 · Paper 1 · Q9 · 10 marksDefine counterfeit medications; explain the issues and solutions with examples.
- Nov 2022 · Paper 4 · Q4 · 10 marksMedication errors - causes and practices to reduce medication errors.
- Nov 2021 · Paper 4 · Q5 · 10 marksOff label use of drugs
- Nov 2021 · Paper 4 · Q7 · 10 marksVaccine vigilance
- Nov 2019 · Paper 1 · Q9 · 10 marksAssessment of drug safety
- May 2019 · Paper 4 · Q7 · 10 marksSpontaneus ADR reporting and causality assessment
- Nov 2018 · Paper 1 · Q1 · 10 marksDiscuss briefly various Adverse drug reactions.
- May 2018 · Paper 1 · Q1 · 10 marksDiscuss Adverse drug reactions.
- Jun 2016 · Paper 1 · Q2 · 20 marksDiscuss the unpredictable adverse drug reactions.
- Jun 2016 · Paper 4 · Q4 · 10 marksPharmacovigilance methods
- Oct 2010 · Paper 1 · Q1 · 20 marksDiscuss the various types of adverse drug reactions. Outline the basic principles of treatment for any case of drug or chemical poisoning.
- May 2010 · Paper 4 · Q1 · 20 marksDiscuss the factors influencing and methods to improve patient compliance
- Apr 2008 · Paper 4 · Q7 · 10 marksCompliance
- Apr 2007 · Paper 4 · Q4 · 10 marksAdverse drug reactions monitoring
- Apr 2006 · Paper 1 · Q6 · 10 marksAdverse drug reaction monitoring
Clinical Toxicology & Poisoning
- Jun 2024 · Paper 1 · Q10 · 10 marksManagement of Acute poisoning and chronic Iron overload
Principles of Clinical Toxicology
- Nov 2021 · Paper 4 · Q8 · 10 marksToxicokinetics
- Nov 2020 · Paper 1 · Q4 · 10 marksPrinciples of therapy in acute poisoning
- Nov 2016 · Paper 1 · Q1 · 20 marksDiscuss the toxic effects of drugs, specific antidotes used and their mode of action.
- Nov 2016 · Paper 4 · Q8 · 10 marksToxicokinetics
Autonomic Neurotransmission
- Sep 2025 · Paper 1 · Q7 · 10 marksSir Henry Dale
- Nov 2016 · Paper 2 · Q8 · 10 marksAutonomic neurotransmitters
Neurotransmission: ANS and Somatic Motor Nervous Systems
- Sep 2025 · Paper 2 · Q1 · 10 marksCo-transmission in the Autonomic Nervous System
Anticholinergic Drugs
- Oct 2008 · Paper 2 · Q5 · 10 marksSub types of muscarinic receptors
Muscarinic Receptor Agonists and Antagonists
- Mar 2026 · Paper 2 · Q4 · 10 marksReceptor subtype specific anticholinergic drugs
- May 2025 · Paper 2 · Q1 · 10 marksNon-Ocular therapeutic uses of anticholinergic drugs
- Jun 2024 · Paper 2 · Q3 · 10 marksTherapeutic uses with rational of cholinergic agonists
- Dec 2023 · Paper 2 · Q9 · 10 marksSAR of anticholinergics
- Jul 2023 · Paper 2 · Q9 · 10 marksSAR of anticholinergics
- May 2022 · Paper 2 · Q3 · 10 marksDiscuss the therapeutic application of atropine and its substitutes
- Nov 2020 · Paper 2 · Q1 · 10 marksAtropine substitutes
- Jun 2020 · Paper 2 · Q9 · 10 marksAtropine and its substitutes
- Jun 2016 · Paper 2 · Q4 · 10 marksAtropine substitutes
Anticholinesterase Inhibitors and Reactivators
- May 2025 · Paper 2 · Q6 · 10 marksRole of oximes in acute intoxication by an anticholinesterase agent
- Nov 2018 · Paper 2 · Q6 · 10 marksManagement of myasthenia gravis
- May 2018 · Paper 2 · Q4 · 10 marksEnzyme reactivators
- Nov 2017 · Paper 2 · Q5 · 10 marksCholinesterase inhibitors in therapeutics
- Oct 2010 · Paper 2 · Q1 · 20 marksDiscuss the pharmacotherapy, limitations and recent advances in the treatment of Myasthenia gravis.
- May 2010 · Paper 2 · Q6 · 10 marksClinical uses of Anticholinesterases.
- May 2009 · Paper 2 · Q5 · 10 marksCholinesterase inhibitors in therapeutics
NMJ, Autonomic Ganglia; Nicotine, Muscle Relaxants, Spasmolytics
- Nov 2022 · Paper 2 · Q1 · 10 marksNon-depolarizing neuromuscular blocking agents
- Nov 2020 · Paper 2 · Q9 · 10 marksCentrally acting skeletal muscle relaxants
- Nov 2019 · Paper 2 · Q6 · 10 marksCompetitive neuromuscular blockers
- Oct 2009 · Paper 2 · Q3 · 10 marksNeuromuscular blocking agents
Drugs in Shock
- Jul 2021 · Paper 2 · Q8 · 10 marksManagement of cardiogenic shock
- May 2010 · Paper 2 · Q4 · 10 marksPlasma Volume Expanders.
Adrenergic Drugs
- Nov 2022 · Paper 2 · Q4 · 10 marksNon-cardiovascular uses of -blockers
Adrenergic Agonists and Antagonists
- Mar 2026 · Paper 2 · Q1 · 10 marksβ selective antagonist in cardiovascular disorders
- Sep 2025 · Paper 2 · Q2 · 10 marksCompare β(Beta) blockers and Calcium channel blockers
- Nov 2022 · Paper 2 · Q3 · 10 marksTherapeutic uses of adrenergic drugs
- May 2022 · Paper 2 · Q6 · 10 marksNon cardiovascular uses of sympathomimetic agents
- Nov 2021 · Paper 2 · Q10 · 10 marksPharmacotherapy of hypovolemic shock
- Jun 2020 · Paper 2 · Q1 · 10 marksDiscuss the current therapeutic status of β-receptor blockers.
- May 2010 · Paper 4 · Q5 · 10 marksClinical evaluation of Beta Adrenergic Blocking Agents
- Sep 2007 · Paper 2 · Q6 · 10 marksSelective beta2 receptor agonists
5-HT (Serotonin) Receptors
- Nov 2021 · Paper 2 · Q9 · 10 marksSerotonergic agents
- May 2011 · Paper 2 · Q5 · 10 marks5-HT antagonists
Dopamine Receptor Pharmacology
- May 2019 · Paper 4 · Q5 · 10 marksDopamine as therapeutic targets
5-HT (Serotonin) and Dopamine
- Mar 2026 · Paper 2 · Q3 · 10 marksPharmacotherapy of migraine
- Sep 2025 · Paper 2 · Q9 · 10 marksManagement of Acute and Chronic migraine; add a note on recent advances
- Nov 2017 · Paper 2 · Q7 · 10 marksPharmacotherapy of migraine
- Nov 2016 · Paper 2 · Q4 · 10 marksRecent advances in Pharmaco therapy of migraine
- Oct 2009 · Paper 2 · Q7 · 10 marksDrugs modulating 5HT receptors in CNS disorders
- May 2009 · Paper 4 · Q2 · 20 marksDescribe the role of serotonin receptors in various clinical disorders
- Apr 2008 · Paper 2 · Q1 · 20 marksDiscuss the pharmacology of serotonin receptors. Add a note on the Pathophysiology and the pharmacotherapy of migraine
- Sep 2006 · Paper 2 · Q5 · 10 marksManagement of migraine
- Apr 2006 · Paper 4 · Q1 · 20 marksDescribe the clinical pharmacology of central dopaminergic receptors.
Central Neurotransmitters and Criteria
- May 2018 · Paper 2 · Q2 · 10 marksInhibitory aminoacid neurotransmitters in CNS and drugs affecting it.
- May 2009 · Paper 2 · Q2 · 20 marksDiscuss the role of inhibitory aminoacid neurotransmitters in CNS and drugs affecting it
- May 2009 · Paper 2 · Q2 · 20 marksSummarise neurotransmitter pharmacology with receptor activity in the central nervous system
- Sep 2007 · Paper 2 · Q8 · 10 marksCentral excitatory neuro-transmitters
NMDA Receptor Antagonists & Clinical Applications
- Jul 2021 · Paper 2 · Q4 · 10 marksRiluzole
- Jun 2016 · Paper 2 · Q1 · 20 marksDiscuss the pharmacology, therapeutic implications and recent advances in glutamate receptors.
- Apr 2008 · Paper 2 · Q8 · 10 marksN-Methyl D-Aspartate (NMDA) receptor antagonists
Peptide Neurotransmitters
- Nov 2021 · Paper 2 · Q8 · 10 marksTachykinins
Neurotransmission in the CNS
- Jun 2024 · Paper 2 · Q2 · 10 marksNMDA receptors antagonists and their clinical application
- Nov 2021 · Paper 2 · Q4 · 10 marksNMDA receptor antagonists
- May 2010 · Paper 2 · Q6 · 10 marksNMDA receptor antagonists
The Blood-Brain Barrier
- Jun 2020 · Paper 1 · Q9 · 10 marksBlood Brain Barrier
- Nov 2019 · Paper 1 · Q6 · 10 marksBlood -Brain barrier
- Apr 2006 · Paper 1 · Q8 · 10 marksBlood brain barrier
Newer Antidepressants
- Mar 2026 · Paper 2 · Q9 · 10 marksRecent advances in pharmacotherapy of mental depression. Add note on their mechanism of action and current status in therapy
- Dec 2023 · Paper 2 · Q4 · 10 marksRecent advances in the pharmacotherapy of depression
- Jul 2023 · Paper 2 · Q4 · 10 marksRecent advances in the pharmacotherapy of depression
- Jun 2016 · Paper 2 · Q5 · 10 marksAnti - anxiety agents
- May 2011 · Paper 2 · Q2 · 20 marksDiscuss the recent concepts in the pharmacotherapy of depression
- May 2010 · Paper 2 · Q4 · 10 marksPharmacotherapy of mental depression
- May 2009 · Paper 2 · Q5 · 10 marksNewer anti depressants
- Sep 2006 · Paper 2 · Q4 · 10 marksAtypical antidepressants
- Apr 2006 · Paper 2 · Q2 · 20 marksDescribe pharmacotherapy of mental depression.
Depression and Anxiety Disorders
- Jun 2024 · Paper 2 · Q5 · 10 marksNewer antidepressants
- Nov 2022 · Paper 2 · Q6 · 10 marksSelective Serotonin Reuptake Inhibitors (SSRIs)
- Nov 2020 · Paper 2 · Q10 · 10 marksSelective Serotonin Reuptake Inhibitors (SSRI)
- Nov 2019 · Paper 2 · Q1 · 10 marksSelective serotonin reuptake inhibitors in mental depression
Atypical Antipsychotics
- May 2011 · Paper 2 · Q8 · 10 marksAdverse effects of chlorpromazine
Pharmacotherapy of Psychosis and Mania
- Mar 2026 · Paper 2 · Q8 · 10 marksStructural activity relationship of phenothiazines
- May 2025 · Paper 2 · Q2 · 10 marksDiscuss the advantages and disadvantages of atypical antipsychotics
- Nov 2022 · Paper 2 · Q5 · 10 marksAtypical antipsychotics
- May 2022 · Paper 2 · Q5 · 10 marksRecent advances in treatment to bipolar disorders
- Nov 2020 · Paper 2 · Q2 · 10 marksAtypical antisychotics
- Jun 2020 · Paper 2 · Q4 · 10 marksLithium carbonate
- Oct 2008 · Paper 2 · Q1 · 20 marksDiscuss the drugs used in treating schizophrenia
GABA Modulators in Epilepsy
- Jun 2024 · Paper 2 · Q7 · 10 marksNon-epileptic uses with rational of antiepileptic drugs
- Nov 2019 · Paper 2 · Q4 · 10 marksDrugs used in absence seizures
- May 2018 · Paper 2 · Q7 · 10 marksAntiepileptics modulating GABA transmission
- Oct 2009 · Paper 2 · Q6 · 10 marksAnti epileptics modulating GABA transmission
- Sep 2006 · Paper 4 · Q3 · 10 marksAnti epileptics
Newer Antiepileptic Drugs & GABA Modulators
- May 2022 · Paper 2 · Q4 · 10 marksNewer anti epileptics
- May 2011 · Paper 2 · Q4 · 10 marksNewer anti-epileptic drugs.
- May 2010 · Paper 2 · Q8 · 10 marksNewer anti-apileptic agents
- Sep 2007 · Paper 2 · Q2 · 20 marksDescribe recent advances in treatment of epilepsy
Pharmacotherapy of the Epilepsies
- Dec 2023 · Paper 2 · Q5 · 10 marksGABA modulators in epilepsy
- Jul 2023 · Paper 2 · Q5 · 10 marksGABA modulators in epilepsy
- May 2019 · Paper 2 · Q7 · 10 marksNewer antiepileptics
- Nov 2018 · Paper 2 · Q7 · 10 marksNewer antiepileptic agents
- May 2011 · Paper 4 · Q6 · 10 marksGabapentin.
- Oct 2010 · Paper 2 · Q3 · 10 marksGABA modulators in Epilepsy.
- May 2009 · Paper 2 · Q3 · 10 marksNewer antiepileptics
Antiparkinsonian Drugs
- May 2025 · Paper 2 · Q5 · 10 marksLevodopa therapy - challenges and solutions
- May 2022 · Paper 2 · Q8 · 10 marksDrugs used for management of Huntington's chorea
- May 2009 · Paper 2 · Q8 · 10 marksCOMT inhibitors
Alzheimer's & Dementia Pharmacotherapy
- Oct 2009 · Paper 2 · Q2 · 20 marksDiscuss in detail about the recent advances in the treatment of Azhermer's disease
CNS Degenerative Disorders
- Mar 2026 · Paper 2 · Q10 · 10 marksPharmacotherapy of Parkinsonism
- Jun 2024 · Paper 2 · Q8 · 10 marksDrug therapy of Alzheimer's disease
- Nov 2020 · Paper 2 · Q6 · 10 marksManagement of Parkinsonism
- Jun 2020 · Paper 2 · Q2 · 10 marksDiscuss the recent advances in the management of Parkinsonism.
- Nov 2017 · Paper 2 · Q6 · 10 marksPharmacotherapy in Parkinsonism
- Nov 2016 · Paper 2 · Q6 · 10 marksDrugs used in treatment of parkinsonism
- Oct 2010 · Paper 2 · Q1 · 20 marksBriefly discuss the Pathophysiology and the pahrmacotherapy of parkinsonisom.
- Oct 2010 · Paper 2 · Q3 · 10 marksPharmacotherapy of Alzheimers disease.
- Oct 2009 · Paper 2 · Q7 · 10 marksDiscuss the use of enzyme inhibitors in the treatment of parkinson's disease
- May 2009 · Paper 2 · Q8 · 10 marksEnzyme inhibitors in Parkinson's diseases
- Apr 2008 · Paper 2 · Q7 · 10 marksPharmacotherapy of parkinsonism
- Sep 2007 · Paper 2 · Q5 · 10 marksTreatment of Alzheimer's disease
- Apr 2007 · Paper 2 · Q1 · 20 marksDiscuss recent advances in treatment of Parkinson's disease.
Neurosteroids
- Nov 2020 · Paper 3 · Q1 · 10 marksNeurosteroids
- Jun 2016 · Paper 3 · Q3 · 10 marksNeurosteroids
- Apr 2007 · Paper 3 · Q8 · 10 marksNeuro steroids
Hypnotics and Sedatives
- Sep 2025 · Paper 2 · Q4 · 10 marksZ - drugs and their advantages
- Nov 2022 · Paper 2 · Q9 · 10 marksNon-benzodiazepine Hypnotics
- Oct 2010 · Paper 2 · Q5 · 10 marksNon benzodiazepine hypnotics.
Cancer Pain and Co-Analgesics
- May 2025 · Paper 2 · Q3 · 10 marksChronic Pain management and recent advances
- Dec 2023 · Paper 2 · Q8 · 10 marksRecent advances in pain therapy
- Jul 2023 · Paper 2 · Q8 · 10 marksRecent advances in pain therapy
- Apr 2006 · Paper 2 · Q1 · 20 marksDescribe recent advances in pain therapy.
Opioid Analgesics
- Nov 2017 · Paper 4 · Q5 · 10 marksNovel analgesic targets
General Anaesthetics
- May 2011 · Paper 2 · Q3 · 10 marksFluorinated anaesthetics
- May 2011 · Paper 4 · Q7 · 10 marksNewer anesthetic agents.
- May 2010 · Paper 2 · Q3 · 10 marksSlow I.V anaesthetic agents
- Oct 2009 · Paper 1 · Q8 · 10 marksPharmacokinetics in inhalational drugs
- Apr 2007 · Paper 2 · Q8 · 10 marksIntravenous anesthetics
- Apr 2006 · Paper 4 · Q7 · 10 marksPreanesthetic medication
General Anesthetics and Therapeutic Gases
- Mar 2026 · Paper 2 · Q6 · 10 marksNon-inhalational anaesthetics
- Sep 2025 · Paper 2 · Q8 · 10 marksJustify the rationale of Balanced anaesthesia
- Jul 2021 · Paper 2 · Q5 · 10 marksPharmacokinetics of inhalational general anaesthetics
- Jun 2020 · Paper 2 · Q3 · 10 marksIntravenous general anesthetics
- Oct 2009 · Paper 2 · Q3 · 10 marksNon inhalational anaesthetic agents
- Oct 2008 · Paper 2 · Q2 · 20 marksDescribe the inhalational general anaesthetics
Cannabinoids
- May 2010 · Paper 2 · Q5 · 10 marksConnabinoids as therapeutic agents.
Cannabinoids
- Mar 2026 · Paper 2 · Q7 · 10 marksCannabinoids as a pharmacological tool
Ethanol and Alcohols
- Jun 2024 · Paper 2 · Q6 · 10 marksPharmacotherapy of alcohol dependence
Drug Dependence, Tolerance & Addiction
- Nov 2018 · Paper 1 · Q10 · 10 marksDrug dependence
- May 2018 · Paper 1 · Q7 · 10 marksDrug tolerance
- May 2009 · Paper 1 · Q7 · 10 marksConsequences of chronic drug use
Drug Use Disorders and Addiction
- Mar 2026 · Paper 4 · Q4 · 10 marksCurrent concepts in drug dependence
- Jun 2024 · Paper 1 · Q7 · 10 marksCompare Tolerance and Dependence
- Nov 2022 · Paper 2 · Q2 · 10 marksNicotine addiction and smoking cessation
- Nov 2021 · Paper 2 · Q1 · 10 marksDrug dependence and treatment of morphine dependence and withdrawal.
- Jul 2021 · Paper 1 · Q5 · 10 marksDrug withdrawal reactions
- May 2019 · Paper 1 · Q8 · 10 marksDrug addiction
- Nov 2018 · Paper 2 · Q4 · 10 marksNon-nicotinic therapies for smoking cessation
- Nov 2017 · Paper 2 · Q8 · 10 marksTreatment of Opium addiction
- Jun 2016 · Paper 1 · Q6 · 10 marksCurrent concept of drug dependence
- May 2011 · Paper 4 · Q1 · 20 marksDiscuss in detail drug abuse by sportspersons.
- May 2011 · Paper 4 · Q8 · 10 marksDesigner Drugs
- May 2009 · Paper 1 · Q8 · 10 marksDrugs of abuse in sports
- Sep 2007 · Paper 2 · Q7 · 10 marksTreatment of Opium addiction
Potassium-Sparing Diuretics
- Nov 2018 · Paper 2 · Q5 · 10 marksInhibitors of renal epithelial cell Na+ channels
- Nov 2017 · Paper 2 · Q4 · 10 marksPotassium sparing diuretics
- Oct 2010 · Paper 2 · Q8 · 10 marksPotassium spanng diuretiecs
- Oct 2009 · Paper 2 · Q4 · 10 marksRenal epithelial Na++ channel inhibitors
- May 2009 · Paper 2 · Q4 · 10 marksPotassium sparing diuretics
- May 2009 · Paper 2 · Q6 · 10 marksPotassium sparing diuretics
High-Ceiling (Loop) Diuretics
- Sep 2025 · Paper 2 · Q6 · 10 marksAdverse effects of Diuretics and measures to ameliorate toxicity
- Oct 2009 · Paper 2 · Q4 · 10 marksRenal inhibitors of Nacl transport system
- Sep 2006 · Paper 2 · Q6 · 10 marksComplications of diuretic therapy
- Sep 2006 · Paper 4 · Q5 · 10 marksDiuretics Write briefly on
Non-Diuretic Uses of Diuretics
- May 2010 · Paper 2 · Q3 · 10 marksOsmotic diuretics as therapeutic agents.
- Apr 2007 · Paper 2 · Q6 · 10 marksOsmotic diuretics
Drugs Affecting Renal Excretory Function (Diuretics)
- Mar 2026 · Paper 2 · Q5 · 10 marksHigh ceiling diuretics
- Dec 2023 · Paper 2 · Q1 · 10 marksNon-diuretic uses of diuretic
- Jul 2023 · Paper 2 · Q1 · 10 marksNon-diuretic uses of diuretic
- Jul 2021 · Paper 2 · Q1 · 10 marksDiuretic resistance
- Nov 2020 · Paper 2 · Q4 · 10 marksLoop diuretics
- Nov 2019 · Paper 2 · Q5 · 10 marksHigh ceiling diuretics
- May 2019 · Paper 2 · Q10 · 10 marksNon-diuretic uses of diuretics
- May 2018 · Paper 4 · Q10 · 10 marksIntravenous fluids
- Oct 2008 · Paper 2 · Q4 · 10 marksRationale of use of potassium sparing diuretics
Renin and Angiotensin
- Dec 2023 · Paper 2 · Q3 · 10 marksDrugs inhibiting renin angiotensin system
- Jul 2023 · Paper 2 · Q3 · 10 marksDrugs inhibiting renin angiotensin system
- May 2022 · Paper 2 · Q2 · 10 marksDrugs affecting RAAS
- Nov 2021 · Paper 2 · Q5 · 10 marksAngiotensin receptor blockers
- Nov 2020 · Paper 2 · Q7 · 10 marksACE inhibitors
- Jun 2020 · Paper 2 · Q5 · 10 marksAngiotensin receptor antagonists
- Nov 2019 · Paper 2 · Q2 · 10 marksAngiotensin converting enzyme inhibitors with special references to treatment of heart failure
- May 2019 · Paper 2 · Q3 · 10 marksAngiotensin receptor antagonists
- Nov 2018 · Paper 2 · Q1 · 10 marksAngiotensin - II receptor blocking agents
- May 2011 · Paper 2 · Q5 · 10 marksAngiotensin receptor antagonists.
- May 2010 · Paper 2 · Q1 · 20 marksDiscuss the pharmacology, limitations and recent advances in Renin Anglotensin Aldosterone System
Antianginal Drugs
- May 2022 · Paper 2 · Q1 · 10 marksClassification of anti anginal drugs and their mechanism of actions
- May 2019 · Paper 2 · Q8 · 10 marksPotassium channel openers
- May 2010 · Paper 2 · Q7 · 10 marksK+ channel modulators
- Oct 2009 · Paper 2 · Q2 · 20 marksDescribe the pathophysiology of myocardial ischemia and pharmacology of drugs modulating these mechanisms
- Apr 2008 · Paper 2 · Q6 · 10 marksPotassium channel openers
Treatment of Ischemic Heart Disease
- Jun 2024 · Paper 2 · Q4 · 10 marksRole of NO in cardiovascular system and coronary vasodilators treatment of angina
- Dec 2023 · Paper 2 · Q10 · 10 marksRecent advances in the management of angina pectoris
- Jul 2023 · Paper 2 · Q10 · 10 marksRecent advances in the management of angina pectoris
- Nov 2021 · Paper 2 · Q2 · 10 marksDrug treatment of acute myocardial infarction and the rationale for the same.
- Nov 2017 · Paper 2 · Q2 · 10 marksRecent advances in the management of Angina.
- Nov 2016 · Paper 2 · Q2 · 20 marksDiscuss the mechanism of action of drugs in ischaemic heart disease.
- Jun 2016 · Paper 2 · Q3 · 10 marksMetabolic modulators in ischemic heart diseases
- Oct 2010 · Paper 2 · Q2 · 20 marksDiscuss the pharmacology and recent advances in the treatment of Ischemic heart Diseases.
- May 2009 · Paper 2 · Q1 · 20 marksDiscuss the role of organic nitrates in therapy
Antihypertensives
- Oct 2010 · Paper 2 · Q7 · 10 marksDrugs useful in pregnant women with Hypertension.
- Oct 2009 · Paper 2 · Q1 · 20 marksDiscuss the role of vasodilators in clinical practice
Treatment of Hypertension
- Mar 2026 · Paper 2 · Q2 · 10 marksMechanism of action, uses and adverse effects of calcium channel blockers
- Sep 2025 · Paper 4 · Q6 · 10 marksRecent trends in treatment of Hypertension
- Jun 2024 · Paper 2 · Q9 · 10 marksHypertensive crisis
- Jun 2020 · Paper 2 · Q7 · 10 marksManagement of hypertensive emergencies
- May 2010 · Paper 2 · Q2 · 20 marksImpact of Comorbiolity on the selection of Antihypertensives. Discuss with appropriate examples.
- Sep 2007 · Paper 2 · Q4 · 10 marksStatus of diuretics in hypertension
- Apr 2006 · Paper 2 · Q5 · 10 marksStatus of beta receptor antagonist in hypertension
Pharmacotherapy of Heart Failure
- Jun 2024 · Paper 2 · Q1 · 10 marksPharmacological treatment of CHF
Therapy of Heart Failure
- May 2025 · Paper 2 · Q7 · 10 marksDrugs used in the treatment of Compensated Heart Failure
- May 2019 · Paper 2 · Q2 · 10 marksDrugs used in congestive cardiac failure.
- Nov 2016 · Paper 2 · Q7 · 10 marksDigoxin toxicity and its management
- Jun 2016 · Paper 2 · Q2 · 20 marksDiscuss the pathophysiology and recent advances in the treatment of congestive cardiac failure.
- May 2011 · Paper 2 · Q1 · 20 marksDiscuss the pharmacotherapy of congestive heart failure.
- May 2010 · Paper 2 · Q8 · 10 marksRole of beta blockers in congestive heart failure
- Oct 2008 · Paper 2 · Q3 · 10 marksCurrent concepts in management of congestive cardiac failure
Antiarrhythmic Drugs and the Vaughan-Williams Classification
- May 2011 · Paper 2 · Q6 · 10 marksPharmacotherapy of ventricular arrythmias.
Antiarrhythmic Drugs
- Sep 2025 · Paper 2 · Q3 · 10 marksNewer antiarrhythmic drugs
- May 2019 · Paper 2 · Q4 · 10 marksClass III antiarrhythmic agents
- Nov 2018 · Paper 2 · Q8 · 10 marksTherapeutic uses of magnesium
- May 2018 · Paper 2 · Q1 · 10 marksClass - I anti arrhythmic drugs
- Oct 2009 · Paper 1 · Q1 · 20 marksDescribe the pharmacology of one group of drugs modulating each ion channel in a cardiac action potential
- May 2009 · Paper 2 · Q1 · 20 marksDescribe the electrophysiology of normal cardiac rhythm, give details of potassium channels. Add a note on anti arrhythmic agents blocking potassium channels
- Apr 2008 · Paper 2 · Q2 · 20 marksDiscuss the mechanisms of cardiac arrhythmias. Classify Anti Arrhythmic Drugs. Discuss the therapeutic uses, Toxic effects and precautions in the use of Amiodarone
- Sep 2006 · Paper 2 · Q2 · 20 marksDescribe the normal electro physiological properties of the myocardium. Discuss the pharmacology and therapeutics and recent advances of the drugs used in the management of cardiac arrhythmias.
Nitric Oxide
- Jul 2021 · Paper 2 · Q9 · 10 marksBiological Vasodilators
- Nov 2019 · Paper 2 · Q8 · 10 marksNitric oxide
- Apr 2007 · Paper 2 · Q3 · 10 marksNitric oxide
- Apr 2006 · Paper 2 · Q3 · 10 marksBiological vasodilators
Pharmacotherapy of Pulmonary Hypertension
- Jun 2024 · Paper 4 · Q7 · 10 marksPharmacotherapy of Pulmonary Hypertension
Treatment of Pulmonary Arterial Hypertension
- Jun 2016 · Paper 2 · Q7 · 10 marksEndothelins
- May 2009 · Paper 4 · Q4 · 10 marksEndothelin receptor antagonists
Oral Anticoagulants — NOACs, Antiplatelets & Fibrinolytics
- Nov 2016 · Paper 2 · Q5 · 10 marksSlow acting anti-coagulants
- Oct 2009 · Paper 2 · Q5 · 10 marksCurrent trends in anti platelet agents
- Sep 2007 · Paper 2 · Q1 · 20 marksDescribe the pharmacotherapy with anti-platelet agents
- Sep 2006 · Paper 3 · Q4 · 10 marksAprotinin
Direct Thrombin Inhibitors
- May 2018 · Paper 2 · Q5 · 10 marksDirect thrombin inhibitors
- May 2018 · Paper 3 · Q10 · 10 marksDirect thrombin inhibitors
- May 2009 · Paper 2 · Q3 · 10 marksDirect thrombin inhibitors
Blood Coagulation: Anticoagulant, Fibrinolytic, Antiplatelet
- Jun 2024 · Paper 2 · Q10 · 10 marksVitamin K dependent anticoagulants
- Jun 2024 · Paper 4 · Q8 · 10 marksPharmacology of Fibrinolytics
- Nov 2022 · Paper 2 · Q8 · 10 marksNewer Oral Anticoagulants
- May 2022 · Paper 2 · Q9 · 10 marksNewer oral anticoagulants
- Jul 2021 · Paper 2 · Q2 · 10 marksAntiplatelet agents
- Nov 2020 · Paper 2 · Q5 · 10 marksOral anticoagulants
- Nov 2019 · Paper 2 · Q9 · 10 marksLow molecular weight heparin
- May 2019 · Paper 2 · Q1 · 10 marksClassify anticoagulants. Discuss the pharmacology of Heparin.
- May 2018 · Paper 2 · Q8 · 10 marksFibrinolytic drugs
- May 2011 · Paper 2 · Q8 · 10 marksLMW heparins.
- Oct 2010 · Paper 2 · Q6 · 10 marksNewer Antiplatelet drugs.
- Oct 2008 · Paper 2 · Q8 · 10 marksWarfarin Sodium
- Apr 2008 · Paper 2 · Q5 · 10 marksRecent Advances in Antiplatelet Drugs
- Apr 2006 · Paper 2 · Q6 · 10 marksNewer fibrinolytic agents
Statins & Pharmacotherapy of Dyslipidemia
- May 2009 · Paper 2 · Q4 · 10 marksRole of stantins in therapy of dyslipedemias
Drug Therapy for Dyslipidemias
- May 2025 · Paper 2 · Q10 · 10 marksNewer targets for treatment of Dyslipidemia
- May 2025 · Paper 4 · Q9 · 10 marksNewer drug targets in dyslipidemia
- Nov 2021 · Paper 2 · Q6 · 10 marksStatins
- Jul 2021 · Paper 2 · Q10 · 10 marksRole of statins in dyslipidemia
- Nov 2018 · Paper 2 · Q3 · 10 marksStatins
- May 2018 · Paper 2 · Q6 · 10 marksRole of statins in therapy of dyslipidemias
- May 2011 · Paper 2 · Q7 · 10 marksHypolipidemic agents
- Sep 2006 · Paper 2 · Q7 · 10 marksSimvastatin
Immunity and Inflammation
- Jun 2016 · Paper 2 · Q6 · 10 marksPlatelet activating factor
- May 2009 · Paper 2 · Q7 · 10 marksPlatelet activating factor antagonists
Calcineurin Inhibitors & Immunosuppressants
- Dec 2023 · Paper 3 · Q2 · 10 marksImmunosuppressants
- Jul 2023 · Paper 3 · Q2 · 10 marksImmunosuppressants
- Nov 2020 · Paper 3 · Q8 · 10 marksImmunosuppressants
- Nov 2018 · Paper 3 · Q7 · 10 marksImmunosuppressants
- May 2010 · Paper 3 · Q4 · 10 marksImmuno suppressants
- Oct 2009 · Paper 3 · Q7 · 10 marksCalcineunin Inhabitors
- May 2009 · Paper 3 · Q4 · 10 marksImmuno suppressive monoclonal Antibodies
- Apr 2006 · Paper 3 · Q7 · 10 marksImmunosupressing agents
Immunomodulators
- Nov 2020 · Paper 3 · Q7 · 10 marksLenalidomide
- Nov 2018 · Paper 3 · Q4 · 10 marksCurrent status of thalidomide
- May 2018 · Paper 3 · Q7 · 10 marksImmuno stimulants
- Oct 2010 · Paper 3 · Q3 · 10 marksImmunomodulators.
- Oct 2010 · Paper 4 · Q8 · 10 marksBiologic response modifiers
- May 2010 · Paper 3 · Q8 · 10 marksThalidomide
- May 2009 · Paper 3 · Q4 · 10 marksImmuno stimulants
Immunosuppressants, Immunomodulation, and Tolerance
- Mar 2026 · Paper 3 · Q10 · 10 marksRapamycin analogues in immunosuppression.
- Sep 2025 · Paper 3 · Q7 · 10 marksCalcineurin inhibitors
- May 2025 · Paper 2 · Q9 · 10 marksBiologic disease modifying anti rheumatic drugs
- May 2025 · Paper 3 · Q7 · 10 marksCalcineurin inhibitors
- Jun 2024 · Paper 3 · Q10 · 10 marksFusion proteins as immunomodulators
- Nov 2022 · Paper 3 · Q7 · 10 marksCalcineurin inhibitors
- May 2022 · Paper 3 · Q7 · 10 marksImmunostimulants and immunomodulators
- Jun 2020 · Paper 3 · Q4 · 10 marksImmunostimulants
- Oct 2010 · Paper 2 · Q4 · 10 marksSteroid sparing agents in Rheumatoid Arthritis.
Vaccines & Immunoglobulins
- Nov 2022 · Paper 4 · Q1 · 10 marksMeasures of Vaccine efficacy and regulation of vaccine trials.
- Jun 2020 · Paper 3 · Q6 · 10 marksNewer vaccines
- Sep 2007 · Paper 3 · Q7 · 10 marksNewer vaccines
Immune Globulins and Vaccines
- Jun 2024 · Paper 3 · Q8 · 10 marksBenefit versus risk of Vaccines in Pandemic
- Jun 2024 · Paper 4 · Q9 · 10 marksVaccine safety - myths, truths and consequences
Eicosanoids — Prostaglandins, Thromboxanes and Leukotrienes
- Jul 2021 · Paper 2 · Q3 · 10 marksTherapeutic uses of prostaglandins
- Nov 2017 · Paper 2 · Q3 · 10 marksTherapeutic uses of Prostaglandins
- Oct 2010 · Paper 3 · Q3 · 10 marksUse of Prostaglandins in obstretics
- Oct 2009 · Paper 2 · Q8 · 10 marksTherapeutic uses of prostaglandins
- May 2009 · Paper 3 · Q6 · 10 marksUterine stimulants
Lipid-Derived Autacoids: Eicosanoids and PAF
- Oct 2010 · Paper 2 · Q4 · 10 marksRole of prostaglandins on therapeutics.
- Oct 2009 · Paper 2 · Q6 · 10 marksClinical use of prostaglandins and its inhibitors
Inflammation, Fever, Pain, and Gout
- Sep 2025 · Paper 4 · Q9 · 10 marksPharmacotherapy of osteoarthritis
- Nov 2021 · Paper 3 · Q6 · 10 marksManagement of Gout
- May 2011 · Paper 2 · Q3 · 10 marksAspirin intolerance.
- May 2010 · Paper 2 · Q7 · 10 marksClinically useful effects of aspirin.
- Apr 2008 · Paper 2 · Q3 · 10 marksSelective Cox2 inhibitors
- Sep 2006 · Paper 2 · Q8 · 10 marksRofecoxib
Histamine, Bradykinin, and Their Antagonists
- Sep 2006 · Paper 4 · Q4 · 10 marksAntihistamines
Bronchial Asthma
- Jun 2020 · Paper 2 · Q10 · 10 marksInhalational glucocorticoids
- Oct 2010 · Paper 2 · Q6 · 10 marksMast cell stabilizers.
- Oct 2009 · Paper 3 · Q7 · 10 marksInhalational corticosteroids
- Oct 2009 · Paper 4 · Q4 · 10 marksOmalizermab
Phosphodiesterase Inhibitors
- May 2011 · Paper 3 · Q7 · 10 marksTherapeutic applications of phosphodiesterase inhibitors
- Apr 2008 · Paper 2 · Q4 · 10 marksPhosphodiesterase inhibitors
Pulmonary Pharmacology
- Sep 2025 · Paper 2 · Q7 · 10 marksGINA guidelines on management of Bronchial Asthma
- May 2025 · Paper 2 · Q4 · 10 marksRole of expectorants and mucolytics in pharmacotherapy of cough
- Dec 2023 · Paper 2 · Q7 · 10 marksImmunomodulators in bronchial asthma
- Jul 2023 · Paper 2 · Q7 · 10 marksImmunomodulators in bronchial asthma
- Nov 2022 · Paper 2 · Q7 · 10 marksGINA guidelines for bronchial asthma
- May 2022 · Paper 2 · Q10 · 10 marksAnti inflammatory agents in Bronchial Asthma
- Nov 2021 · Paper 2 · Q7 · 10 marksPharmacology of airway remodeling in bronchial asthma
- Jul 2021 · Paper 2 · Q7 · 10 marksPharmacotherapy of cough
- Nov 2020 · Paper 2 · Q3 · 10 marksCorticosteroids in Bronchial Asthma
- Nov 2020 · Paper 4 · Q8 · 10 marksScreening of new molecular with anti-asthmatic activity
- Nov 2019 · Paper 2 · Q7 · 10 marksBronchodilators in COPD
- May 2019 · Paper 2 · Q9 · 10 marksPharmacotherapy of bronchial asthma
- Nov 2018 · Paper 2 · Q9 · 10 marksBronchodilators
- May 2018 · Paper 2 · Q3 · 10 marksPharmacotherapy of cough
- Nov 2017 · Paper 2 · Q9 · 10 marksLeukotriene modifiers in bronchial asthma
- May 2011 · Paper 2 · Q7 · 10 marksLeukotriene antagonists.
- Oct 2010 · Paper 2 · Q2 · 20 marksDiscuss the Pharmacotherapy of branchial asthma
- Oct 2010 · Paper 2 · Q5 · 10 marksInhalational agents used in Bronchial Asthma.
- May 2010 · Paper 2 · Q1 · 20 marksDiscuss recent advances in the management of Bronchial Asthma.
- May 2010 · Paper 2 · Q2 · 20 marksDiscuss in detail the recent advances in the treatment of bronchial asthma
- Oct 2009 · Paper 4 · Q5 · 10 marksInhibitors of leukotrienes
- May 2009 · Paper 2 · Q6 · 10 marksAnti inflammatory agents in Bronchial Asthma
- Oct 2008 · Paper 2 · Q6 · 10 marksNon- narcotic anti-tussive agents
- Apr 2007 · Paper 2 · Q2 · 20 marksDescribe recent advances in pharmacotherapy of bronchial asthma.
- Sep 2006 · Paper 2 · Q1 · 20 marksDiscuss the recent advances in the management of bronchial asthma
- Apr 2006 · Paper 2 · Q8 · 10 marksMucolytic agents
Haematopoietic Growth Factors & Agents
- Dec 2023 · Paper 2 · Q2 · 10 marksErythropoietin
- Jul 2023 · Paper 2 · Q2 · 10 marksErythropoietin
- Jun 2020 · Paper 2 · Q6 · 10 marksMolgramostim
- Nov 2018 · Paper 2 · Q2 · 10 marksHaemopoietic growth factors with their clinical significance.
- Nov 2017 · Paper 2 · Q1 · 10 marksHaemopoietic growth factors and their analogues in therapeutics.
- Oct 2010 · Paper 2 · Q7 · 10 marksErythropoietin.
- May 2010 · Paper 2 · Q5 · 10 marksMyeloid growth factors
- Apr 2007 · Paper 2 · Q4 · 10 marksErythropoietin
Hematopoietic Agents: Growth Factors, Minerals, Vitamins
- Sep 2025 · Paper 2 · Q10 · 10 marksRole of Haematopoietic factors in Cancer chemotherapy induced myelosuppression
- Sep 2025 · Paper 3 · Q3 · 10 marksSargramostim
- Jul 2021 · Paper 4 · Q8 · 10 marksAntioxidants
- Nov 2019 · Paper 4 · Q5 · 10 marksInjectable iron preparation and its indications
- Oct 2009 · Paper 2 · Q1 · 20 marksDiscuss the role of Haematopoietic growth factors and their analoges in therapeutics
Hypothalamic & Pituitary Drugs
- May 2022 · Paper 3 · Q2 · 10 marksDrugs used in Assisted reproduction
- May 2009 · Paper 3 · Q2 · 20 marksDescribe the pharmacology of agents used in 'assisted Reproductive Techniques'
Hypothalamic-Pituitary Axis
- Sep 2025 · Paper 3 · Q10 · 10 marksManagement of Acromegaly
- Dec 2023 · Paper 3 · Q1 · 10 marksGNRH analogues
- Jul 2023 · Paper 3 · Q1 · 10 marksGNRH analogues
- Jul 2021 · Paper 3 · Q10 · 10 marksAnti Diuretic Hormone (ADH) and its uses
- Jun 2020 · Paper 3 · Q7 · 10 marksGonadotropin Releasing Hormone analogs
- May 2019 · Paper 3 · Q9 · 10 marksVasopressin receptor antagonists
- May 2018 · Paper 2 · Q9 · 10 marksVasopressin receptor antagonists
- May 2018 · Paper 3 · Q3 · 10 marksProlactin inhibitors
- May 2011 · Paper 4 · Q5 · 10 marksVasopressin receptor antagonists
- May 2010 · Paper 3 · Q3 · 10 marksGn RH analogs
- Oct 2008 · Paper 3 · Q7 · 10 marksGonadotrophic Release Hormone Analogs
- Apr 2007 · Paper 3 · Q4 · 10 marksSomatostatin analogs
- Apr 2006 · Paper 2 · Q7 · 10 marksVasopressin (ADH) analogues
Antithyroid Drugs & Radioactive Iodine
- Jul 2021 · Paper 3 · Q3 · 10 marksRadioactive substances in therapeutics
- Sep 2007 · Paper 3 · Q8 · 10 marksRadio-isotopes
Drug Therapy of Hypothyroidism
- Nov 2019 · Paper 3 · Q9 · 10 marksThroxine
Thyroid and Antithyroid Drugs
- Mar 2026 · Paper 3 · Q1 · 10 marksWrite the mechanism of action, pharmacokinetics and uses of Propylthiouracil.
- May 2019 · Paper 3 · Q5 · 10 marksDrug therapy of thyrotoxic crisis
- Nov 2017 · Paper 3 · Q3 · 10 marksRadioactive isotopes of iodine
- May 2010 · Paper 3 · Q7 · 10 marksDrug treatment of Thyrotoxic crisis with rationale for the use of each drug.
- Oct 2009 · Paper 3 · Q1 · 20 marksOutline the steps in the biosynthesis of thyroid hormones. Discuss drugs therapy of thyrotoxicosis
- Oct 2009 · Paper 3 · Q5 · 10 marksRadio active isotopes of iodine
- Apr 2008 · Paper 3 · Q3 · 10 marksRadioactive Iodine
- Apr 2006 · Paper 3 · Q6 · 10 marksTreatment of hyperthyroid crisis
Tocolytics
- Nov 2019 · Paper 3 · Q2 · 10 marksDrugs acting on uterus.
- May 2018 · Paper 3 · Q2 · 10 marksPharmacology of drugs acting on uterus
- Nov 2017 · Paper 3 · Q8 · 10 marksTocolyties
- Oct 2009 · Paper 3 · Q6 · 10 marksUterine stimulants and relaxants
SERMs, SERDs & Tocolytics
- Jun 2024 · Paper 3 · Q2 · 10 marksSelective Estrogen Receptors Modulators
- Nov 2022 · Paper 3 · Q3 · 10 marksSelective estrogen receptor down regulators
- Jul 2021 · Paper 3 · Q5 · 10 marksSelective estrogen receptor modulators
Estrogens and Progestins
- May 2009 · Paper 4 · Q6 · 10 marksNon-surgical termination of pregnancy
Oral Contraceptives & HRT
- Oct 2009 · Paper 3 · Q8 · 10 marksCurrent conclusions in H R T
Estrogens, Progestins, Female Reproductive Tract
- Sep 2025 · Paper 3 · Q8 · 10 marksCurrent status of Hormone Replacement Therapy in Women
- May 2025 · Paper 3 · Q6 · 10 marksSelective estrogen receptor modulators (SERMs)
- May 2025 · Paper 3 · Q8 · 10 marksTocolytics.
- Jun 2024 · Paper 3 · Q7 · 10 marksContraindications for Oral contraceptive pills
- May 2022 · Paper 3 · Q3 · 10 marksTocolytics
- Nov 2021 · Paper 3 · Q2 · 10 marksSelective Estrogen Receptor Modulators (SERM)
- Nov 2020 · Paper 3 · Q3 · 10 marksTocolytics
- May 2019 · Paper 3 · Q7 · 10 marksOral contraceptive pills
- May 2018 · Paper 3 · Q4 · 10 marksNon-contraceptive uses of oral contraceptives
- Nov 2017 · Paper 3 · Q4 · 10 marksHormone replacement therapy in post menopausal women
- Nov 2016 · Paper 3 · Q8 · 10 marksTherapeutic uses of estrogens
- Jun 2016 · Paper 3 · Q8 · 10 marksSelective Estrogen Receptor Modulators (SERMs)
- May 2011 · Paper 3 · Q8 · 10 marksHormone replacement therapy
- Oct 2010 · Paper 3 · Q6 · 10 marksSERMs.
- Oct 2009 · Paper 3 · Q3 · 10 marksHormone replacement therapy
- May 2009 · Paper 3 · Q8 · 10 marksAnti progestins
- Oct 2008 · Paper 3 · Q1 · 20 marksDiscuss the Neuroendocrine regulation of Menstrual Cycle and the role of Oral contraceptives in females
- Oct 2008 · Paper 3 · Q3 · 10 marksMifepristone
- Oct 2008 · Paper 3 · Q8 · 10 marksTocolytic agents
- Sep 2007 · Paper 3 · Q2 · 20 marksDescribe recent advances in hormonal contraceptives
- Apr 2006 · Paper 3 · Q3 · 10 marksTocolytic agents
- Apr 2006 · Paper 3 · Q4 · 10 marksAnti oestrogens
Androgens and Male Reproductive Tract
- Sep 2025 · Paper 3 · Q9 · 10 marksAndrogen receptor modulators
- Jun 2024 · Paper 4 · Q4 · 10 marksDiscuss about Anabolic steroids
- Jun 2020 · Paper 3 · Q3 · 10 marksAntiandrogens
- Nov 2019 · Paper 3 · Q7 · 10 marksGossypol
- May 2011 · Paper 3 · Q6 · 10 marksFinasteride
- May 2011 · Paper 3 · Q8 · 10 marksMale contraceptives
- Oct 2010 · Paper 3 · Q5 · 10 marksAnabolic steroids
- May 2010 · Paper 3 · Q5 · 10 marksAnabolic steroids
- Apr 2008 · Paper 3 · Q5 · 10 marksAntiandrogens
- Apr 2007 · Paper 2 · Q5 · 10 marksNon surgical treatment of benign prostatic hypertrophy
Corticosteroids — Non-endocrine Uses & Long-term Effects
- May 2010 · Paper 3 · Q6 · 10 marksTopical steroids.
- May 2009 · Paper 4 · Q8 · 10 marksRole of steroids in critical care
- Oct 2008 · Paper 3 · Q6 · 10 marksTopical steroids
Adrenocorticotropic Hormone, Adrenal Steroids, Adrenal Cortex
- Dec 2023 · Paper 3 · Q5 · 10 marksUses of Corticosteroids for non-endocrine diseases and adverse effects on long term use
- Jul 2023 · Paper 3 · Q5 · 10 marksUses of Corticosteroids for non-endocrine diseases and adverse effects on long term use
- Jun 2020 · Paper 3 · Q10 · 10 marksSpecial dosage forms of glucocorticoids and their indications
- May 2019 · Paper 3 · Q1 · 10 marksLong term toxicities of glucocorticoids and methods to minimise them
- Nov 2016 · Paper 3 · Q7 · 10 marksAdverse effects of glucocorticoids
Newer Oral Antidiabetics & SGLT2 Inhibitors
- Dec 2023 · Paper 3 · Q4 · 10 marksEpalrestat
- Dec 2023 · Paper 3 · Q7 · 10 marksSodium- Glucose transport protein two inhibitors
- Jul 2023 · Paper 3 · Q4 · 10 marksEpalrestat
- Jul 2023 · Paper 3 · Q7 · 10 marksSodium- Glucose transport protein two inhibitors
- Nov 2022 · Paper 3 · Q2 · 10 marksNewer oral anti-diabetic drugs
- Jul 2021 · Paper 3 · Q1 · 10 marksOral antidiabetic agents
- Nov 2020 · Paper 3 · Q2 · 10 marksInsulin secretagogues
- Nov 2018 · Paper 3 · Q8 · 10 marksInsulin secretogogues
- Nov 2016 · Paper 3 · Q2 · 20 marksDiscuss the antidiabetic agents in the treatment of type-2 diabetes.
- Jun 2016 · Paper 3 · Q1 · 20 marksDiscuss the recent advances in the pharmacotherapy of Type-II Diabetes Mellitus.
- May 2011 · Paper 3 · Q7 · 10 marksRepaglinide
- Oct 2010 · Paper 3 · Q1 · 20 marksDiscuss the current status of Oral antidiabetic drugs
- Oct 2010 · Paper 3 · Q4 · 10 marksRecent advances in management of type-II Diabetes mellitus.
- May 2010 · Paper 3 · Q2 · 20 marksDiscuss pharmacology newer anti-diabetic agents
- May 2010 · Paper 3 · Q2 · 20 marksDiscuss the recent advances in the management of diabetes mellitus
- May 2010 · Paper 3 · Q5 · 10 marksNewer anti-diabetic agents
- Apr 2008 · Paper 3 · Q1 · 20 marksDiscuss current status of hypoglycemic agents
Insulin Sensitizers
- Oct 2010 · Paper 4 · Q3 · 10 marksPPARs and their role in drug development
Obesity Pharmacotherapy
- May 2010 · Paper 4 · Q3 · 10 marksAnti obesity drugs
Endocrine Pancreas: Diabetes Mellitus
- Mar 2026 · Paper 3 · Q8 · 10 marksWrite in detail on Insulin Sensitisers.
- Sep 2025 · Paper 3 · Q6 · 10 marksInsulin delivery devices
- May 2025 · Paper 3 · Q10 · 10 marksPharmacotherapy of Diabetic Ketoacidosis.
- May 2022 · Paper 3 · Q1 · 10 marksNewer insulin preparations and management of Diabetic emergencies.
- Nov 2021 · Paper 3 · Q1 · 10 marksInsulin formulations
- Jun 2020 · Paper 3 · Q8 · 10 marksNewer drug delivery systems of insulin
- Nov 2019 · Paper 3 · Q5 · 10 marksNewer Insulins
- May 2019 · Paper 3 · Q4 · 10 marksThiazolidinediones
- Nov 2017 · Paper 3 · Q2 · 10 marksIncretins in Diabetes mellitus.
- May 2011 · Paper 3 · Q6 · 10 marksDPP-4 inhibitor
- Oct 2009 · Paper 3 · Q2 · 20 marksDescribe the role of Incretins in therapy of Diabetes mellitus
- May 2009 · Paper 3 · Q6 · 10 marksInsulin sensitizers
- Sep 2007 · Paper 3 · Q6 · 10 marksNewer drug delivery systems of insulin
Mineral Ion Homeostasis and Bone Turnover
- Sep 2025 · Paper 3 · Q1 · 10 marksAgents affecting Bone Turnover
- Nov 2022 · Paper 3 · Q1 · 10 marksDrug therapy of osteoporosis
- May 2022 · Paper 3 · Q4 · 10 marksBisphosphonates
- Jul 2021 · Paper 3 · Q4 · 10 marksBisphosphonates
- Nov 2018 · Paper 3 · Q2 · 10 marksDiscuss the recent advances in the treatment of osteoporosis.
- May 2011 · Paper 3 · Q4 · 10 marksBisphosphonates
- Oct 2010 · Paper 3 · Q4 · 10 marksBisphosphonates
- Apr 2007 · Paper 3 · Q5 · 10 marksBisphosphonates
- Apr 2006 · Paper 3 · Q8 · 10 marksVitamin D
Peptic Ulcer Disease — Anti-ulcer Drugs, H. pylori & GERD
- Nov 2021 · Paper 2 · Q3 · 10 marksH2 - receptor Antagonists
- May 2019 · Paper 2 · Q6 · 10 marksProton pump inhibitors
- Nov 2018 · Paper 2 · Q10 · 10 marksProton pump inhibitors
- May 2011 · Paper 2 · Q6 · 10 marksDrug therapy of gastro oesophageal reflux disease.
- Oct 2009 · Paper 2 · Q8 · 10 marksTreatment of H pylori infection
- May 2009 · Paper 2 · Q7 · 10 marksProton pump inhibitors
- Sep 2007 · Paper 2 · Q3 · 10 marksProton pump inhibitors
Gastric Acidity, PUD, GERD
- Sep 2025 · Paper 4 · Q10 · 10 marksClinical pharmacology of peptic ulcer treatment
- May 2025 · Paper 2 · Q8 · 10 marksPharmacotherapy of Gastroesophageal Reflux Disease
- Dec 2023 · Paper 2 · Q6 · 10 marksAnti-helicobacter pylori therapy
- Jul 2023 · Paper 2 · Q6 · 10 marksAnti-helicobacter pylori therapy
- May 2022 · Paper 2 · Q7 · 10 marksAnti H.Pylori therapy
- Nov 2020 · Paper 2 · Q8 · 10 marksDrugs for H.Pylori infection
- Jun 2020 · Paper 2 · Q8 · 10 marksAnti-Helicobacter pylori drugs
- May 2011 · Paper 2 · Q2 · 20 marksDiscuss in detail the recent advances in the treatment of peptic ulcer.
- Oct 2010 · Paper 2 · Q8 · 10 marksRole of anti-bacterial agents in the treatment of peptic ulcer.
- May 2009 · Paper 3 · Q7 · 10 marksDrug therapy of GERD
Antiemetics and Prokinetic Drugs
- Jul 2021 · Paper 2 · Q6 · 10 marksProkinetic agents
GI Motility, Emesis, Biliary, Pancreatic
- Nov 2019 · Paper 2 · Q10 · 10 marksProkinetics
- May 2018 · Paper 2 · Q10 · 10 marksSelective 5HT3 antagonists
- Nov 2017 · Paper 4 · Q10 · 10 marksOral Rehydration Salts (ORS)
- Nov 2016 · Paper 2 · Q1 · 20 marksExplain the recent advances in pharmaco therapy of emesis.
- Oct 2009 · Paper 2 · Q5 · 10 marksAntiemetic agents
- Oct 2008 · Paper 2 · Q7 · 10 marksNewer - anti emetics
- Apr 2007 · Paper 2 · Q7 · 10 marksRehydration therapy
- Sep 2006 · Paper 2 · Q3 · 10 marksPro-Kinetic Agents
Pharmacotherapy of Inflammatory Bowel Disease
- Jun 2016 · Paper 2 · Q8 · 10 marksPharmacotherapy of Inflammatory Bowel Diseases.
Inflammatory Bowel Disease
- Sep 2025 · Paper 2 · Q5 · 10 marksPharmacotherapy of Inflammatory Bowel Disease
- Apr 2006 · Paper 2 · Q4 · 10 marksTreatment of ulcerative colitis
General Principles of Antimicrobial Therapy
- Mar 2026 · Paper 4 · Q9 · 10 marksThe WHO AWaRe (Access, Watch, Reserve) classification of antibiotics
- May 2025 · Paper 3 · Q2 · 10 marksPost antibiotic effect-implications in therapeutics
- Dec 2023 · Paper 3 · Q6 · 10 marksManagement of Opportunistic infections
- Jul 2023 · Paper 3 · Q6 · 10 marksManagement of Opportunistic infections
- Jun 2020 · Paper 3 · Q1 · 10 marksRational use of antibiotics
- May 2018 · Paper 3 · Q1 · 10 marksProblems that arise with the use of antimicrobial agents
- May 2011 · Paper 4 · Q5 · 10 marksPseudo membranous colitis.
- Oct 2009 · Paper 3 · Q5 · 10 marksPost anti biotic effect - implications in therapeutics
- May 2009 · Paper 3 · Q1 · 20 marksIllustrate with examples the rational use of antibiotics in chemotherapy
Mechanisms of Antimicrobial Resistance
- Nov 2020 · Paper 3 · Q9 · 10 marksMechanism of resistance to antimicrobial agents
- May 2019 · Paper 3 · Q2 · 10 marksDiscuss bacterial drug resistance.
- May 2011 · Paper 3 · Q4 · 10 marksResistance to antibiotics
General Principles of Antimicrobial Therapy
- Jun 2024 · Paper 3 · Q1 · 10 marksWrite in detail on antimicrobial FDCs with rationale
- Nov 2022 · Paper 3 · Q10 · 10 marksGeneral principles of antimicrobial therapy
- Nov 2016 · Paper 3 · Q1 · 20 marksDiscuss the guiding principles for selection of antimicrobial agents.
- May 2011 · Paper 3 · Q3 · 10 marksChemoprophylaxis in operative procedures
- Oct 2010 · Paper 3 · Q8 · 10 marksSuperinfections.
- May 2010 · Paper 3 · Q1 · 20 marksDiscuss pharmacology of newer broad spectrum antimicrobial agents and add a note om principles for the selection of antimicrobial agents
Fluoroquinolones, Metronidazole & DHFR Inhibitors
- Jun 2024 · Paper 3 · Q4 · 10 marksManagement of Chronic recurrent Urinary Tract Infection
- May 2011 · Paper 3 · Q1 · 20 marksDiscuss the role of antimicrobials in the treatment of Urinary tract
Typhoid Fever Pharmacotherapy
- May 2018 · Paper 4 · Q9 · 10 marksPharmacotherapy of Enteric fever
DNA Disruptors: Sulfonamides, Quinolones, Nitroimidazoles
- Mar 2026 · Paper 3 · Q4 · 10 marksMechanism of action, therapeutic uses and adverse effects of Fluoroquinolones.
- Nov 2022 · Paper 3 · Q4 · 10 marksNewer fluoroquinolones
- May 2022 · Paper 3 · Q6 · 10 marksDrugs used in anaerobic infections
- May 2022 · Paper 3 · Q8 · 10 marksDihydrofolate reductase inhibitors
- May 2022 · Paper 3 · Q10 · 10 marksMetronidazole and its analogues
- Nov 2019 · Paper 3 · Q4 · 10 marksFluroquinolones
- May 2019 · Paper 3 · Q6 · 10 marksDNA gyrase inhibitors
- Nov 2018 · Paper 3 · Q5 · 10 marksDrugs used in an anaerobic infections
- May 2018 · Paper 3 · Q6 · 10 marksNewer fluroquinolones
- Oct 2010 · Paper 3 · Q7 · 10 marksII Generation Fluoroquinolones
- Oct 2009 · Paper 3 · Q4 · 10 marksDihydrofolate Reductase inhibitors
- May 2009 · Paper 3 · Q5 · 10 marksDNA gyrase Inhibitors
- Sep 2006 · Paper 3 · Q2 · 20 marksDiscuss the current clinical status of quinolones.
Penicillins and Cell-Wall-Synthesis Inhibitors
- Nov 2018 · Paper 3 · Q9 · 10 marksBeta lactamase inhibitors
Cell Envelope Disruptors: β-Lactams, Glycopeptides, Lipopeptides
- Sep 2025 · Paper 3 · Q4 · 10 marksGlycopeptides antimicrobials
- May 2025 · Paper 3 · Q9 · 10 marksSecond Generation Cephalosporins.
- Jun 2024 · Paper 3 · Q5 · 10 marksAntipseudomonal Penicillins and Cephalosporins
- Dec 2023 · Paper 3 · Q3 · 10 marksFourth generation cephalosporins
- Jul 2023 · Paper 3 · Q3 · 10 marksFourth generation cephalosporins
- Jul 2021 · Paper 3 · Q9 · 10 marksThird generation cephalosporins
- Jun 2016 · Paper 3 · Q5 · 10 marksNewer β-lactam antibiotics
- May 2010 · Paper 3 · Q3 · 10 marksPenicillins- current clinical status.
- Apr 2007 · Paper 3 · Q1 · 20 marksGive a detailed account of newer Cephalosporins in the present day management of infections. Indicate the advantages of each generation.
- Sep 2006 · Paper 3 · Q8 · 10 marksAnti-pseudomonal cephalosporins
Newer Antibacterial Agents
- Nov 2018 · Paper 3 · Q10 · 10 marksTigecycline
- Oct 2010 · Paper 3 · Q2 · 20 marksDiscuss the recent advances in the management of Pseudomonas infections.
Miscellaneous Antibacterials: Aminoglycosides, Polymyxins
- Mar 2026 · Paper 3 · Q5 · 10 marksMethods to prevent Aminoglycoside antibiotic toxicity.
- Nov 2021 · Paper 3 · Q9 · 10 marksAminoglycosides
- Nov 2020 · Paper 3 · Q5 · 10 marksPlazomicin
- May 2018 · Paper 3 · Q9 · 10 marksAnti pseudomonal agents
- Jun 2016 · Paper 3 · Q7 · 10 marksAnti - pseudomonal agents
- May 2010 · Paper 3 · Q7 · 10 marksAnti psendomonal drugs
- Sep 2007 · Paper 3 · Q5 · 10 marksTreatment of pseudomonas infection
Macrolides, Ketolides & Streptogramins
- May 2009 · Paper 3 · Q1 · 20 marksDiscuss the pharmacology of protein synthesis inhibitors as antibacterial agents
Protein Synthesis Inhibitors
- May 2025 · Paper 3 · Q5 · 10 marksMacrolides
- May 2022 · Paper 3 · Q5 · 10 marksStreptogramins
- Oct 2010 · Paper 3 · Q7 · 10 marksNewer macrolide antibiotics
- Oct 2009 · Paper 3 · Q6 · 10 marksStreptogramins
- Apr 2008 · Paper 3 · Q8 · 10 marksClinical uses and Drug interactions of macrolide antibiotics
- Sep 2006 · Paper 3 · Q7 · 10 marksNewer macrolides
Antifungal Drugs
- Nov 2019 · Paper 3 · Q3 · 10 marksDrugs used in Superficial Fungal infections
- Nov 2018 · Paper 3 · Q6 · 10 marksTopical antifungal agents
- Nov 2017 · Paper 3 · Q5 · 10 marksTopical antifungal agents
- Oct 2009 · Paper 3 · Q8 · 10 marksAnti fungal agents
- May 2009 · Paper 3 · Q8 · 10 marksTopical antifungals
- Oct 2008 · Paper 3 · Q2 · 20 marksDiscuss briefly about the drugs used in systemic fungal infections
- Apr 2008 · Paper 3 · Q4 · 10 marksDrugs used in the treatment of Dandruff
Antifungal Agents
- Jun 2024 · Paper 3 · Q3 · 10 marksCompare the formulations of Amphotericin-B
- Nov 2021 · Paper 3 · Q4 · 10 marksAmphotericin B
- Nov 2020 · Paper 3 · Q4 · 10 marksEchinocandins
- Nov 2016 · Paper 3 · Q3 · 10 marksAzole antifungal agents
- May 2011 · Paper 3 · Q3 · 10 marksEchinocandins
Antiviral Agents (Nonretroviral)
- Dec 2023 · Paper 3 · Q10 · 10 marksAnti influenza agents
- Jul 2023 · Paper 3 · Q10 · 10 marksAnti influenza agents
- Nov 2021 · Paper 3 · Q10 · 10 marksNeurominidase inhibitors
- May 2019 · Paper 3 · Q3 · 10 marksNeuraminidase inhibitors
- Oct 2010 · Paper 3 · Q8 · 10 marksOseltamavir
- Apr 2008 · Paper 3 · Q7 · 10 marksAntiherpes-virus agents
- Sep 2007 · Paper 3 · Q1 · 20 marksDiscuss pharmacology of anti-viral agents
Treatment of Viral Hepatitis (HBV/HCV)
- Jun 2024 · Paper 3 · Q6 · 10 marksProdrugs used in the treatment of Hepatitis B infection; add a note on investigational agents
Antiretroviral Drugs
- May 2009 · Paper 3 · Q2 · 20 marksDiscuss in detail the recent advances in the treatment of AIDS
Antiretroviral Agents and HIV Treatment
- Sep 2025 · Paper 3 · Q2 · 10 marksMulti drug therapy of HIV infections and discuss about Post Exposure Prophylaxis
- May 2025 · Paper 3 · Q3 · 10 marksEnfuvirtide
- Jun 2024 · Paper 3 · Q9 · 10 marksEntry inhibitors in the treatment of HIV infection
- Nov 2022 · Paper 3 · Q6 · 10 marksProtease inhibitors
- Jul 2021 · Paper 3 · Q2 · 10 marksRecent advances in the treatment of HIV infection.
- Nov 2020 · Paper 3 · Q6 · 10 marksFusion inhibitors
- Jun 2020 · Paper 3 · Q5 · 10 marksHighly Active Anti Retroviral Therapy (HAART)
- May 2018 · Paper 4 · Q7 · 10 marksNewer drug targets for Antiretroviral therapy
- Nov 2017 · Paper 3 · Q1 · 10 marksProtease inhibitors
- Jun 2016 · Paper 3 · Q4 · 10 marksRegimes in - antiretroviral therapy
- May 2011 · Paper 3 · Q2 · 20 marksDiscuss NACO (National AIDS Control Organization) guidelines for treating AIDS Also give in brief about newer antiretrovirals.
- May 2011 · Paper 3 · Q5 · 10 marksNevirapine
- May 2010 · Paper 4 · Q6 · 10 marksDrugs useful in opportunistic infections in AIDS patients
- May 2009 · Paper 3 · Q3 · 10 marksHAART Regimens
- Sep 2006 · Paper 3 · Q5 · 10 marksNevirapine
- Sep 2006 · Paper 3 · Q6 · 10 marksProtease inhibitors
Antitubercular Drugs
- Mar 2026 · Paper 3 · Q6 · 10 marksTreatment and prophylaxis of MAC infections.
- Nov 2016 · Paper 3 · Q6 · 10 marksDOTS-PLUS
- Apr 2007 · Paper 3 · Q2 · 20 marksClassify antituberculous drugs. Describe the various drug regimens in the treatment of tuberculosis. Add a note on tuberculosis associated with acquired immuno deficiency syndrome.
Tuberculosis and NTM, Leprosy
- Sep 2025 · Paper 3 · Q5 · 10 marksLatest guidelines in drug therapy of Tuberculosis in India
- May 2025 · Paper 3 · Q1 · 10 marksDrugs used in mycobacterium avium complex
- Nov 2022 · Paper 3 · Q5 · 10 marksDelamanid
- Nov 2021 · Paper 3 · Q8 · 10 marksMulti Drug Resistant Tuberculosis
- Jul 2021 · Paper 3 · Q7 · 10 marksDrugs for Mycobacterium avium complex
- Jun 2020 · Paper 3 · Q2 · 10 marksFirst line of anti tubercular drugs
- Nov 2019 · Paper 3 · Q1 · 10 marksChemotherapy of tuberculosis. Add a special note on revised guidelines (RNTCP)
- Nov 2019 · Paper 3 · Q8 · 10 marksDrugs used in Leprosy
- May 2019 · Paper 3 · Q10 · 10 marksFirst line Antitubercular drugs
- Nov 2018 · Paper 3 · Q3 · 10 marksAnti leprotic drugs
- Nov 2017 · Paper 3 · Q9 · 10 marksMulti drug resistant tuberculosis
- Oct 2010 · Paper 3 · Q2 · 20 marksDiscuss the chemotherapy of tuberculosis
- Oct 2010 · Paper 3 · Q5 · 10 marksDOTS and chemoprophylaxis in tuberculosis.
- May 2010 · Paper 3 · Q4 · 10 marksDrugs used in mycobacterium avium complex with their adverse effects.
- Oct 2009 · Paper 3 · Q3 · 10 marksX-DR Tuberculosis and its treatment
- May 2009 · Paper 3 · Q3 · 10 marksExtreme drug resistant tuberculosis
- Apr 2008 · Paper 3 · Q2 · 20 marksDiscuss pharmacology of drugs used in the treatment of Tuberculosis with a note on importance of multidrug therapy
- Sep 2007 · Paper 3 · Q3 · 10 marksDrugs used for Mycobacterium avium complex
- Apr 2006 · Paper 3 · Q5 · 10 marksAdvances in treatment of leprosy
Chemotherapy of Malaria
- Mar 2026 · Paper 3 · Q2 · 10 marksPharmacotherapy of drug resistant Plasmodium falciparum Malaria.
- Nov 2022 · Paper 3 · Q9 · 10 marksDrugs used in chloroquine resistant malaria
- Nov 2021 · Paper 3 · Q3 · 10 marksChloroquine resistant malaria
- Jul 2021 · Paper 3 · Q8 · 10 marksTreatment of cerebral malaria
- Nov 2018 · Paper 3 · Q1 · 10 marksDrugs used in chemotherapy of malaria and add a note on management of chloroquine resistant falciparum malaria.
- May 2018 · Paper 3 · Q8 · 10 marksNewer anti-malarial drugs.
- Nov 2017 · Paper 3 · Q10 · 10 marksArtemisinin compounds
- Nov 2016 · Paper 3 · Q4 · 10 marksChemoprophylaxis of malaria
- Jun 2016 · Paper 3 · Q2 · 20 marksDiscuss recent advances in the treatment of malaria. Briefly outline the treatment of cerebral malaria.
- Oct 2010 · Paper 3 · Q6 · 10 marksArtemisinin derivatives
- Oct 2009 · Paper 3 · Q2 · 20 marksDiscuss the recent advances in the management of malaria
- Apr 2006 · Paper 3 · Q1 · 20 marksDescribe the pharmacotherapy of P. Falciparum malaria
Chelation Therapy
- May 2009 · Paper 1 · Q4 · 10 marksChernobyl unclear reactor accident
- Oct 2008 · Paper 1 · Q4 · 10 marksDrugs used in lead poisoning
Anthelmintic Drugs
- Nov 2017 · Paper 3 · Q7 · 10 marksIvermectin
Chemotherapy of Helminth Infections
- Mar 2026 · Paper 3 · Q9 · 10 marksIvermectin and its newer analogues.
Anticancer Drugs: Classification and Principles
- Nov 2019 · Paper 3 · Q10 · 10 marksAlkylating agents in cancer chemotherapy
- May 2018 · Paper 3 · Q5 · 10 marksAntimetabolites used in cancer chemotherapy
- Nov 2016 · Paper 3 · Q5 · 10 marksAlkylating agents
- May 2011 · Paper 3 · Q2 · 20 marksGive an account of Topoisomerase inhibitors in cancer chemotherapy
- May 2010 · Paper 3 · Q8 · 10 marksDrug treatment regimens used in cancer chemotherapy
- Oct 2008 · Paper 3 · Q4 · 10 marksMethothrexate
- Apr 2007 · Paper 3 · Q6 · 10 marksFolate antagonists as therapeutic agents
Cytoprotective & Ameliorative Agents in Cancer Chemotherapy
- Oct 2009 · Paper 4 · Q7 · 10 marksAmifostine
General Principles of Cancer Pharmacotherapy
- Dec 2023 · Paper 3 · Q9 · 10 marksAmeliorative measures in cancer chemotherapy
- Jul 2023 · Paper 3 · Q9 · 10 marksAmeliorative measures in cancer chemotherapy
- Nov 2021 · Paper 3 · Q7 · 10 marksCytoprotectives in Cancer therapy
- Nov 2020 · Paper 3 · Q10 · 10 marksToxicity amelioration of anticancer drugs
Vinca Alkaloids, Taxanes & Anticancer Antibiotics
- May 2022 · Paper 3 · Q9 · 10 marksAntibiotics used in cancer chemotherapy
- Jun 2020 · Paper 3 · Q9 · 10 marksPlant alkaloids in cancer chemotherapy
- May 2010 · Paper 3 · Q1 · 20 marksDiscuss the role of antibiotics in cancer chemotherapy
- Apr 2006 · Paper 3 · Q2 · 20 marksDescribe the current status of plant products used in malignancy
Cytotoxics and Antimetabolites
- Mar 2026 · Paper 3 · Q3 · 10 marksVinca alkaloids - mechanism of action, therapeutic uses and adverse effects.
- Nov 2021 · Paper 3 · Q5 · 10 marksMitotic Spindle inhibitors
- Oct 2009 · Paper 3 · Q1 · 20 marksDiscuss the pharmacology of anticancer antibiotics
- Apr 2007 · Paper 3 · Q3 · 10 marksPaclitaxel
Protein Kinase Inhibitors in Cancer Chemotherapy
- May 2009 · Paper 3 · Q7 · 10 marksTyrosine Kinase Inhibitors
Protein Kinase Inhibitors and Pathway-Targeted Small Molecules
- Mar 2026 · Paper 3 · Q7 · 10 marksMEK inhibitors in Cancer chemotherapy.
Monoclonal Antibodies & Immunotherapy in Cancer
- Jun 2016 · Paper 4 · Q7 · 10 marksPharmacology of angiogenesis
Antibodies, CAR T Cells, Proteins for Cancer
- Sep 2025 · Paper 4 · Q7 · 10 marksRituximab
- May 2025 · Paper 3 · Q4 · 10 marksMonoclonal antibodies in cancer therapy
- Nov 2022 · Paper 3 · Q8 · 10 marksMonoclonal antibodies in cancer chemotherapy
- Nov 2019 · Paper 3 · Q6 · 10 marksMonoclonal antibodies
- Nov 2017 · Paper 3 · Q6 · 10 marksMonoclonal antibodies in cancer chemotherapy
- May 2011 · Paper 3 · Q1 · 20 marksDiscuss the role of monoclonal antibodies in treating various malignant conditions
- May 2009 · Paper 3 · Q5 · 10 marksMonoclonal antibodies in cancer chemotherapy
Hormonal Agents in Cancer Therapy
- Jul 2021 · Paper 3 · Q6 · 10 marksHormones used in malignancy
- Oct 2010 · Paper 3 · Q1 · 20 marksDiscuss the role of hormones and their antagonists in cancer therapy.
- Sep 2007 · Paper 3 · Q4 · 10 marksHormones as snit-malignant agents
Hormones in Cancer Therapy
- Apr 2007 · Paper 3 · Q7 · 10 marksAromatase inhibitors
Ocular Pharmacology & Glaucoma
- Sep 2025 · Paper 1 · Q8 · 10 marksDrug induced ocular toxicity
- Nov 2019 · Paper 2 · Q3 · 10 marksPharmacotherapy of Glaucoma
- May 2019 · Paper 2 · Q5 · 10 marksPharmacotherapy of glaucoma
Ocular Pharmacology
- Nov 2016 · Paper 2 · Q3 · 10 marksDrugs used in glaucoma
- May 2011 · Paper 2 · Q1 · 20 marksDiscuss the pharmacology, limitations and recent advances in the treatment of glaucoma.
Antiseptics & Disinfectants
- May 2010 · Paper 3 · Q6 · 10 marksTopical antibacterial preparations
Dermatological Pharmacology
- Dec 2023 · Paper 3 · Q8 · 10 marksTreatment of Psoriasis
- Jul 2023 · Paper 3 · Q8 · 10 marksTreatment of Psoriasis
- Nov 2019 · Paper 4 · Q9 · 10 marksAntiseptics and disinfectants
- May 2019 · Paper 3 · Q8 · 10 marksDrugs for Psoriasis
- Jun 2016 · Paper 3 · Q6 · 10 marksAntiseptics and disinfectants
- Oct 2008 · Paper 3 · Q5 · 10 marksPuva therapy
- Apr 2008 · Paper 3 · Q6 · 10 marksEctoparasiticides
- Sep 2006 · Paper 3 · Q1 · 20 marksDiscuss the pharmacology of topical dermatologic therapeutic agents.
Environmental Toxicology
- Sep 2025 · Paper 1 · Q6 · 10 marksAdverse impact of drug in the ecosystem and preventive measures
Phases of Clinical Trials in Drug Development
- Jul 2021 · Paper 4 · Q2 · 10 marksDiscuss the principles of controlled clinical trials.
- Nov 2020 · Paper 4 · Q7 · 10 marksImportance of clinical trial Audit
- Nov 2020 · Paper 4 · Q9 · 10 marksClinical trial designs
- Jun 2020 · Paper 4 · Q3 · 10 marksTherapeutic exploratory trials
- Nov 2018 · Paper 4 · Q1 · 10 marksPhases of clinical trials.
- Nov 2018 · Paper 4 · Q4 · 10 marksRole of investigator and sponsor in clinical research
- Jun 2016 · Paper 4 · Q3 · 10 marksPhases of clinical trials
- Jun 2016 · Paper 4 · Q6 · 10 marksRole of biostatistician in clinical research
- Oct 2009 · Paper 4 · Q1 · 20 marksDescribe the phases and their requirements in New Drug Development
- Oct 2009 · Paper 4 · Q8 · 10 marksPhase V clinical trials
- Oct 2008 · Paper 4 · Q2 · 20 marksDiscuss in detail clinical evaluation of drugs
- Apr 2006 · Paper 4 · Q5 · 10 marksGCP Trials
Student t-Test in Biostatistics
- May 2025 · Paper 1 · Q9 · 10 marksStudent's t test
- Nov 2022 · Paper 1 · Q7 · 10 marksStudent's t-test
- Nov 2020 · Paper 1 · Q7 · 10 marksStudent 't' test
- Jun 2020 · Paper 1 · Q10 · 10 marksStudent's t test
- May 2019 · Paper 1 · Q6 · 10 marksPaired 't' test
- May 2018 · Paper 1 · Q3 · 10 marksStudent's t-test
- Sep 2006 · Paper 1 · Q7 · 10 marksStudents 'T' test
Chi-square Test
- Jun 2024 · Paper 1 · Q5 · 10 marksChi-square test
- May 2022 · Paper 1 · Q3 · 10 marksChi-square test
- Nov 2021 · Paper 1 · Q9 · 10 marksChi square test
- Nov 2017 · Paper 1 · Q3 · 10 marksChi-square test
- Oct 2008 · Paper 1 · Q3 · 10 marksChi Square Test
- Sep 2007 · Paper 1 · Q5 · 10 marksChi square test
Drugs in Pregnancy & Lactation
- Nov 2018 · Paper 1 · Q9 · 10 marksTeratogenicity
- Nov 2017 · Paper 1 · Q6 · 10 marksFetal effects of maternal drug exposure
- Oct 2008 · Paper 1 · Q8 · 10 marksTeratogenicity
- Sep 2007 · Paper 1 · Q8 · 10 marksTeratogenicity
- Apr 2007 · Paper 1 · Q2 · 20 marksDiscuss various factors to be considered while prescribing drug therapy to females
Laboratory Animals in Pharmacology
- Nov 2022 · Paper 4 · Q2 · 10 marksGuinea pig as an experimental animal.
- Nov 2019 · Paper 4 · Q4 · 10 marksAnimal handling techniques
- Nov 2018 · Paper 4 · Q7 · 10 marksRat as an experimental animal
- Nov 2016 · Paper 4 · Q7 · 10 marksGuinea pig as an experimental animal
- May 2009 · Paper 4 · Q7 · 10 marksEthics in animal experiments
New Drug Development & Approval Process
- Jun 2024 · Paper 4 · Q5 · 10 marksDiscuss about phases of drug discovery
- Nov 2016 · Paper 4 · Q1 · 20 marksDiscuss the various steps involved in the development of new drug.
- May 2011 · Paper 4 · Q3 · 10 marksDrug approval in India.
- May 2011 · Paper 4 · Q4 · 10 marksRegulatory bodies in clinical trails
- Oct 2010 · Paper 4 · Q1 · 20 marksDescribe the preclinical evaluation of an investigational molecule for new drug development
Non-parametric Tests
- Dec 2023 · Paper 1 · Q4 · 10 marksNon parametric tests
- Jul 2023 · Paper 1 · Q4 · 10 marksNon parametric tests
- May 2019 · Paper 4 · Q4 · 10 marksNon parametric tests
- Nov 2018 · Paper 1 · Q7 · 10 marksNon-parametric tests
- Oct 2009 · Paper 1 · Q4 · 10 marksNon-parametric tests
Blinding, Randomization & Allocation Concealment in Clinical Trials
- Nov 2017 · Paper 4 · Q6 · 10 marksRandomized trials
- Nov 2016 · Paper 4 · Q5 · 10 marksRandomized trials
- May 2010 · Paper 1 · Q4 · 10 marksMethods of avoiding experimental bias
- Oct 2009 · Paper 4 · Q6 · 10 marksRandomized clinical trial
High-Performance Liquid Chromatography (HPLC) in Pharmacology
- May 2022 · Paper 1 · Q4 · 10 marksHPLC
- Nov 2018 · Paper 4 · Q3 · 10 marksHPLC
- May 2011 · Paper 1 · Q7 · 10 marksPrinciples of HPLC.
- May 2010 · Paper 1 · Q4 · 10 marksPrinciples of HPLC
P-drugs & Rational Prescribing
- May 2019 · Paper 1 · Q7 · 10 marks'P' drug concept
- Nov 2018 · Paper 4 · Q5 · 10 marksProblem based pharmacotherapy.
- Nov 2018 · Paper 4 · Q8 · 10 marks'P' drug concept
- Apr 2007 · Paper 4 · Q3 · 10 marksFactors affecting the prescribing habits of physicians
P-value and Statistical Significance
- Nov 2016 · Paper 1 · Q4 · 10 marksNull hypothesis
- Oct 2009 · Paper 1 · Q3 · 10 marksNull hypothesis
- May 2009 · Paper 1 · Q3 · 10 marksProbability values and related tests
- May 2009 · Paper 1 · Q5 · 10 marksP value
Measures of Central Tendency and Dispersion
- Nov 2017 · Paper 1 · Q7 · 10 marksStandard error
- Jun 2016 · Paper 1 · Q7 · 10 marksStandard error
- May 2011 · Paper 1 · Q7 · 10 marksSampling errors
ARO-CRO Model in Clinical Trials
- Jun 2016 · Paper 4 · Q8 · 10 marksAcademia - Industry interactions in drug development
- Oct 2010 · Paper 4 · Q1 · 20 marksIndia is emerging as a hub for clinical research - Discuss
Declaration of Helsinki and Ethical Principles in Research
- Nov 2017 · Paper 4 · Q1 · 10 marksDiscuss the evolution of ethics in clinical research.
- Apr 2007 · Paper 1 · Q6 · 10 marksEthics In clinical research
Drugs in Renal Failure
- Jun 2016 · Paper 1 · Q8 · 10 marksNephrotoxic drugs
- Sep 2006 · Paper 1 · Q8 · 10 marksNephrotoxic drugs
Fixed-Dose Combinations (FDC)
- Nov 2017 · Paper 4 · Q8 · 10 marksFixed dose drug combinations-merits and demerits
- Oct 2009 · Paper 4 · Q3 · 10 marksDisadvantages of fixed dose combination formulations
Informed Consent in Clinical Research
- Nov 2021 · Paper 4 · Q3 · 10 marksInformed consent
- Nov 2018 · Paper 1 · Q4 · 10 marksInformed consent
Pediatric Pharmacology
- Oct 2008 · Paper 1 · Q6 · 10 marksDrugs not to be prescribed in children
- Sep 2007 · Paper 1 · Q2 · 20 marksDiscuss clinical significance of drug therapy in neonates
Alternatives to Animal Experiments
- Oct 2009 · Paper 1 · Q5 · 10 marksIn-vitro model system in toxicology
Bioassay
- May 2010 · Paper 4 · Q4 · 10 marksAnimal test to observe effect of drugs on salivary flow
Drugs in Hepatic Failure
- Apr 2008 · Paper 1 · Q3 · 10 marksHepatotoxic drugs
Flame Photometry in Analytical Pharmacology
- Nov 2018 · Paper 1 · Q3 · 10 marksSpectrophotometry
High-Throughput Screening
- Jun 2024 · Paper 4 · Q6 · 10 marksHigh Throughput Screening (HTS)
Meta-Analysis and Systematic Review
- Oct 2010 · Paper 4 · Q4 · 10 marksMetaanalysis
Placebo & the Placebo Effect
- Sep 2006 · Paper 4 · Q8 · 10 marksUse of controls in experiments
Screening Methods for Antiepileptic Drugs
- Nov 2020 · Paper 4 · Q2 · 10 marksPre-clinical and clinical evaluation of a new anti-convulsant drug
Screening Methods for Antifertility Agents
- Apr 2007 · Paper 4 · Q1 · 20 marksDiscuss the experimental and clinical evaluation of antifertility drugs.
Screening Methods for Antihypertensive Drugs
- Oct 2009 · Paper 4 · Q2 · 20 marksDescribe the methods of evaluation of anti hypertensive drugs
Screening of Antianxiety Drugs
- Jun 2020 · Paper 4 · Q2 · 10 marksDiscuss about the development of a new drug with anti-anxiety activity
Miscellaneous
- Mar 2026 · Paper 1 · Q10 · 10 marksP-drugs (Personal drugs)
- Mar 2026 · Paper 4 · Q1 · 10 marksRegistration and Quorum Requirement for Institutional Ethics Committee.
- Mar 2026 · Paper 4 · Q2 · 10 marksCPCSEA guidelines -4-Rs in alternatives to animal testing.
- Mar 2026 · Paper 4 · Q5 · 10 marksScreening methods for anti-inflammatory drugs
- Mar 2026 · Paper 4 · Q6 · 10 marksAdvantages of High Throughput Screening.
- Mar 2026 · Paper 4 · Q10 · 10 marksDrug promotional literature- types and criteria for critical review.
- Sep 2025 · Paper 1 · Q1 · 10 marksType-I and Type-II errors in biostatistics
- Sep 2025 · Paper 1 · Q5 · 10 marksDescribe the types of data with examples and relevant method of representation
- Sep 2025 · Paper 1 · Q9 · 10 marksWrite in detail on 'Safe Drug Therapy' during lactation
- Sep 2025 · Paper 1 · Q10 · 10 marksPlacebo
- Sep 2025 · Paper 4 · Q2 · 10 marksP-drug
- Sep 2025 · Paper 4 · Q3 · 10 marksAlternatives to the use of animals in drug research
- Sep 2025 · Paper 4 · Q8 · 10 marksBlinding and allocation concealment in clinical trials
- May 2025 · Paper 1 · Q4 · 10 marksPrinciples of High Performance Liquid Chromatography (HPLC)
- May 2025 · Paper 1 · Q5 · 10 marksTransgenic animals
- May 2025 · Paper 1 · Q6 · 10 marksDouble blind tests
- May 2025 · Paper 1 · Q7 · 10 marksFour point assay
- May 2025 · Paper 1 · Q10 · 10 marksEssential drugs
- May 2025 · Paper 4 · Q1 · 10 marksDescribe several phases of clinical evaluation of newly introduced drugs. What are the problems likely to be met with?
- May 2025 · Paper 4 · Q3 · 10 marksAlternatives to the use of animals in drug research
- May 2025 · Paper 4 · Q4 · 10 marksDeclaration of Helsinki
- May 2025 · Paper 4 · Q7 · 10 marksClinical trial registry
- May 2025 · Paper 4 · Q8 · 10 marksScreening of new anti-cancer drug
- Jun 2024 · Paper 1 · Q4 · 10 marksDrug administration and dosage modulation in renal disease
- Jun 2024 · Paper 4 · Q3 · 10 marksDiscuss about Carcinogenicity and Mutagenicity
- Jun 2024 · Paper 4 · Q10 · 10 marksAnimal models of Alzheimer's disease
- Dec 2023 · Paper 1 · Q1 · 10 marksPerinatal pharmacology
- Dec 2023 · Paper 1 · Q6 · 10 marksRadio immunoassay
- Dec 2023 · Paper 1 · Q8 · 10 marksFlame photometry
- Dec 2023 · Paper 4 · Q1 · 10 marksMethods of screening drugs for peptic ulcer.
- Dec 2023 · Paper 4 · Q2 · 10 marksDrug toxicity studies.
- Dec 2023 · Paper 4 · Q5 · 10 marksGeneral principles of bioassay
- Dec 2023 · Paper 4 · Q8 · 10 marksEvaluation of antipsychotic agents
- Jul 2023 · Paper 1 · Q1 · 10 marksPerinatal pharmacology
- Jul 2023 · Paper 1 · Q6 · 10 marksRadio immunoassay
- Jul 2023 · Paper 1 · Q8 · 10 marksFlame photometry
- Jul 2023 · Paper 4 · Q1 · 10 marksMethods of screening drugs for peptic ulcer.
- Jul 2023 · Paper 4 · Q2 · 10 marksDrug toxicity studies.
- Jul 2023 · Paper 4 · Q5 · 10 marksGeneral principles of bioassay
- Jul 2023 · Paper 4 · Q8 · 10 marksEvaluation of antipsychotic agents
- Nov 2022 · Paper 1 · Q2 · 10 marksDiscuss the principles of administration of drugs during pregnancy.
- Nov 2022 · Paper 1 · Q5 · 10 marksEssential medicine(s) concept
- Nov 2022 · Paper 1 · Q6 · 10 marksPhase-I clinical trials
- Nov 2022 · Paper 4 · Q5 · 10 marksInformed consent document.
- Nov 2022 · Paper 4 · Q6 · 10 marksTransgenic animals and their use as models for Alzheimer's disease.
- Nov 2022 · Paper 4 · Q8 · 10 marksOrphan drugs and new guidelines for New Drugs and Clinical Trial rules 2019 (NDCT 2019)
- Nov 2022 · Paper 4 · Q9 · 10 marksMaze types and use in experiments on laboratory animals.
- Nov 2022 · Paper 4 · Q10 · 10 marksNew concept of ARO-CRO model in clinical trials.
- May 2022 · Paper 1 · Q5 · 10 marksEssential drug concept
- May 2022 · Paper 1 · Q6 · 10 marksClinical significance of administration of drugs during pregnancy
- May 2022 · Paper 1 · Q10 · 10 marksInstitutional Ethics Committee.
- May 2022 · Paper 4 · Q1 · 10 marksScreening methods for evaluation anti-fertility agents
- May 2022 · Paper 4 · Q3 · 10 marksTypes of review in Ethics Committee
- May 2022 · Paper 4 · Q4 · 10 marksEssential drugs
- May 2022 · Paper 4 · Q5 · 10 marksPlacebo
- May 2022 · Paper 4 · Q8 · 10 marksPrinciples of Declaration of Helsinki
- May 2022 · Paper 4 · Q9 · 10 marksPrerequisites of new drug application
- May 2022 · Paper 4 · Q10 · 10 marksNew Drugs and Clinical Trials Rules 2019
- Nov 2021 · Paper 1 · Q3 · 10 marksAcute toxicity studies
- Nov 2021 · Paper 1 · Q4 · 10 marksRadioimmunoassay
- Nov 2021 · Paper 1 · Q10 · 10 marksPharmacokinetics of drugs in Elderly
- Nov 2021 · Paper 4 · Q1 · 10 marksScreening methods for evaluating anti-inflammatory agents
- Nov 2021 · Paper 4 · Q6 · 10 marksRandomization
- Nov 2021 · Paper 4 · Q9 · 10 marksCONSORT statement
- Nov 2021 · Paper 4 · Q10 · 10 marksComposition and functions of Ethics Committee
- Jul 2021 · Paper 1 · Q2 · 10 marksClinical significance of drugs used in geriatrics
- Jul 2021 · Paper 1 · Q6 · 10 marksAnimal toxicity studies
- Jul 2021 · Paper 1 · Q7 · 10 marksKaplan Meier Curve
- Jul 2021 · Paper 1 · Q8 · 10 marksRadioimmunoassay
- Jul 2021 · Paper 1 · Q10 · 10 marksFixed dose combination of drugs
- Jul 2021 · Paper 4 · Q1 · 10 marksMethods of evaluating anti-inflammatory drugs
- Jul 2021 · Paper 4 · Q3 · 10 marksTransgenic animals
- Jul 2021 · Paper 4 · Q7 · 10 marksEvaluation of Diuretics
- Jul 2021 · Paper 4 · Q9 · 10 marksAlternatives to animal experiments
- Jul 2021 · Paper 4 · Q10 · 10 marksEssential drug list
- Nov 2020 · Paper 1 · Q5 · 10 marksEssential drug concept
- Nov 2020 · Paper 1 · Q6 · 10 marksRadioimmunoassay
- Nov 2020 · Paper 1 · Q8 · 10 marksInstitutional Ethics Committee
- Nov 2020 · Paper 4 · Q1 · 10 marksTransgenic animals in drug development
- Nov 2020 · Paper 4 · Q3 · 10 marksCPCSEA
- Nov 2020 · Paper 4 · Q4 · 10 marksPre-clinical toxicity studies
- Nov 2020 · Paper 4 · Q5 · 10 marksImpact Factor
- Nov 2020 · Paper 4 · Q6 · 10 marksBiomarkers in clinical evaluation of new drugs
- Nov 2020 · Paper 4 · Q10 · 10 marksPhase zero clinical trials
- Jun 2020 · Paper 1 · Q6 · 10 marksInstitutional Ethics Committee
- Jun 2020 · Paper 4 · Q1 · 10 marksWrite in detail about 'Ethics in Clinical Trials'. Mention the role of Placebo
- Jun 2020 · Paper 4 · Q5 · 10 marks3R concepts in animal experiments
- Jun 2020 · Paper 4 · Q7 · 10 marksInformed consent form
- Jun 2020 · Paper 4 · Q8 · 10 marksScreening of new molecule with anti-pyretic activity
- Jun 2020 · Paper 4 · Q9 · 10 marksPhase zero clinical trials
- Nov 2019 · Paper 1 · Q1 · 10 marksDiscuss the factors affecting drug treatment in elderly.
- Nov 2019 · Paper 1 · Q3 · 10 marksPrinciples of radioimmunoassay
- Nov 2019 · Paper 1 · Q5 · 10 marksTransgenic animals in research
- Nov 2019 · Paper 1 · Q10 · 10 marksMeta analysis
- Nov 2019 · Paper 4 · Q1 · 10 marksDescribe the various animal toxicity studies.
- Nov 2019 · Paper 4 · Q2 · 10 marksPhases of clinical evaluations of drugs
- Nov 2019 · Paper 4 · Q6 · 10 marksRole of placebo
- Nov 2019 · Paper 4 · Q10 · 10 marksScreening methods for Anti-inflammatory agents
- May 2019 · Paper 1 · Q2 · 10 marksPharmacokinetics of drugs during pregnancy
- May 2019 · Paper 4 · Q2 · 10 marksEvaluation techniques for Antianginal drugs.
- May 2019 · Paper 4 · Q6 · 10 marksFlame photometer
- May 2019 · Paper 4 · Q9 · 10 marksPlacebo
- Nov 2018 · Paper 4 · Q2 · 10 marksScreening methods for 'anti-peptic ulcer agent'.
- Nov 2018 · Paper 4 · Q9 · 10 marksRandomization
- May 2018 · Paper 1 · Q2 · 10 marksPrinciples of administration of drugs in paediatric practice.
- May 2018 · Paper 1 · Q6 · 10 marksInstitutional Ethics Committee
- May 2018 · Paper 1 · Q8 · 10 marksRadioimmunoassay
- May 2018 · Paper 4 · Q2 · 10 marksScreening methods to evaluate a compound for its Anti-inflammatory activity.
- May 2018 · Paper 4 · Q3 · 10 marksEthics committee - composition and responsibilities
- May 2018 · Paper 4 · Q4 · 10 marksEvidence based medicine
- May 2018 · Paper 4 · Q6 · 10 marksAnimal models for testing learning & memory in rats
- Nov 2017 · Paper 4 · Q2 · 10 marksDiscuss the screening methods to evaluate a compound for Antiepileptic activity.
- Nov 2017 · Paper 4 · Q3 · 10 marksEvaluation of Anti-asthmatic drugs in animal models
- Nov 2016 · Paper 1 · Q3 · 10 marksCost benefit analysis of drugs
- Nov 2016 · Paper 4 · Q2 · 20 marksDiscuss the methods used to screen a compound suppose to have antiepileptic activity.
- Nov 2016 · Paper 4 · Q6 · 10 marksPlacebo
- Jun 2016 · Paper 4 · Q1 · 20 marksDiscuss the evolution of Ethical issues in Clinical Research and outline the principles of Declaration of Helsinki.
- Jun 2016 · Paper 4 · Q2 · 20 marksDiscuss the methods involved in screening of a potential anti - inflammatory agent.
- May 2011 · Paper 1 · Q2 · 20 marksDiscuss in detail about clinical significance of administration of drugs in elderly patients.
- May 2011 · Paper 1 · Q4 · 10 marksConfidence intervals
- May 2011 · Paper 1 · Q8 · 10 marksPlacebo.
- May 2011 · Paper 2 · Q4 · 10 marksAnimal models for screening antiepilepsy drugs
- May 2011 · Paper 4 · Q1 · 20 marksDescribe the screening methods of an investigational molecule for anti anxiety activity
- May 2011 · Paper 4 · Q2 · 20 marksDescribe the role of placebo in clinical trials.
- May 2011 · Paper 4 · Q4 · 10 marksMethods involved in screening of a compound having analgesic activity.
- May 2011 · Paper 4 · Q7 · 10 marksRational Drug use
- Oct 2010 · Paper 1 · Q5 · 10 marksPrinciples of ELISA
- Oct 2010 · Paper 1 · Q8 · 10 marksANOVA and its applications
- Oct 2010 · Paper 4 · Q2 · 20 marksDiscuss the components of rational drug use
- Oct 2010 · Paper 4 · Q2 · 20 marksDiscuss the methods involved in screening of a potential anti - diabetic agent
- Oct 2010 · Paper 4 · Q4 · 10 marksIND and NDA applications
- Oct 2010 · Paper 4 · Q5 · 10 marksEssential drugs (Medicines) concept
- Oct 2010 · Paper 4 · Q5 · 10 marksHigh throughput screening
- Oct 2010 · Paper 4 · Q7 · 10 marksTeratogenecity
- Oct 2010 · Paper 4 · Q8 · 10 marksPhase 0 clinical trials
- May 2010 · Paper 1 · Q1 · 20 marksDiscuss in detail the clinical significance of administration of drugs in Geriatric practice
- May 2010 · Paper 1 · Q3 · 10 marksTests of mutagenicity
- May 2010 · Paper 1 · Q6 · 10 marksTransgenic animals
- May 2010 · Paper 1 · Q8 · 10 marksANOVA
- May 2010 · Paper 4 · Q1 · 20 marksWrite about experimental evaluation of a drug claimed to have Analgesic properties
- May 2010 · Paper 4 · Q2 · 20 marksDiscuss the methods involved in screening a compound supposed to have anti ulcer activity
- May 2010 · Paper 4 · Q2 · 20 marksHow will you proceed to conduct clinical trial of an antiepileptic drug
- May 2010 · Paper 4 · Q5 · 10 marksConfidence intervals
- May 2010 · Paper 4 · Q6 · 10 marksDouble Blind Study
- May 2010 · Paper 4 · Q7 · 10 marksAlternatives to the use of animals in drug research
- Oct 2009 · Paper 1 · Q5 · 10 marksBiostandardization
- Oct 2009 · Paper 1 · Q6 · 10 marksApplications and methodology of PCR
- Oct 2009 · Paper 1 · Q6 · 10 marksType I and Type II errors
- Oct 2009 · Paper 4 · Q2 · 20 marksDescribe the screening methods of an investigational molecule for anti-ulcer activity
- Oct 2009 · Paper 4 · Q7 · 10 marksRadio immunoassay
- May 2009 · Paper 1 · Q3 · 10 marksChronic toxicity studies
- May 2009 · Paper 4 · Q1 · 20 marksDescribe preclinical toxicity studies
- May 2009 · Paper 4 · Q1 · 20 marksDiscuss the prerequisites and methodology for the conduct of phase II clinical trial of a new Anti hypertensive agent
- May 2009 · Paper 4 · Q2 · 20 marksDescribe the screening methods of an investigational molecule for antiepileptic activity
- May 2009 · Paper 4 · Q3 · 10 marksEvaluation of anti peptic ulcer agents
- May 2009 · Paper 4 · Q4 · 10 marksTransgenic animals
- May 2009 · Paper 4 · Q5 · 10 marksTransgenic animals
- Oct 2008 · Paper 4 · Q1 · 20 marksDescribe the methods of screening drugs for peptic ulcer
- Oct 2008 · Paper 4 · Q5 · 10 marksDescribe the experimental evaluation of Analgesics
- Oct 2008 · Paper 4 · Q6 · 10 marksDescribe the experimental evaluation of Anti-hypertensives
- Oct 2008 · Paper 4 · Q7 · 10 marksDescribe the experimental evaluation of Anti-cancer drugs
- Oct 2008 · Paper 4 · Q8 · 10 marksDescribe the experimental evaluation of Anti-fertility drugs
- Apr 2008 · Paper 1 · Q6 · 10 marksEssential drugs
- Apr 2008 · Paper 4 · Q1 · 20 marksDescribe modified declaration of Helsinki
- Apr 2008 · Paper 4 · Q2 · 20 marksWrite in detail about the methods for evaluation of anti anxiety drugs
- Sep 2007 · Paper 4 · Q2 · 20 marksDescribe animal toxicity studies of drug.
- Sep 2007 · Paper 4 · Q3 · 10 marksAnimal evaluation of antipsychotic agents
- Sep 2007 · Paper 4 · Q5 · 10 marksScreening methods for oral anti-diabetic agents
- Sep 2007 · Paper 4 · Q7 · 10 marksImportance of randomization, blinding & crossing over in a clinical trial
- Apr 2007 · Paper 1 · Q3 · 10 marksSample size calculation in clinical trials
- Apr 2007 · Paper 4 · Q2 · 20 marksDiscuss the therapeutic problems in pediatric patients. Add a note on non-compliance and the importance of dose regulations in children.
- Apr 2007 · Paper 4 · Q8 · 10 marksInstitutional ethical committee
- Sep 2006 · Paper 4 · Q1 · 20 marksDescribe in detail the various methods of evaluating anti-inflammatory drugs.
- Sep 2006 · Paper 4 · Q7 · 10 marksGeneral principles of bioassay
- Apr 2006 · Paper 1 · Q7 · 10 marksSelection of drugs during pregnancy
- Apr 2006 · Paper 4 · Q4 · 10 marksAnimal model for drugs affecting memory
- Apr 2006 · Paper 4 · Q6 · 10 marksPhase I clinical trials
Frequently asked
Where do these RGUHS questions come from?
They are reproduced from RGUHS MD Pharmacology theory papers: 1,245 questions from 30 exam sessions between 2006 and 2026, collected in the PharmaNotes Pro question index.
Are answers included?
Each topic links to its PharmaNotes Pro chapter; the introduction is free to read, full answers are for subscribers at ₹199/month or ₹1,999/year. The chapters are written from the standard textbooks; they are not official university answers.
How are the questions arranged?
By topic, newest first within each topic. Each question shows its exam session and, where the paper records them, the paper, question number and marks.
Answers in PharmaNotes Pro
Each topic links to its PharmaNotes Pro chapter; the introduction is free to read, full answers are for subscribers at ₹199/month or ₹1,999/year.
All universities → DNB question papers → MUHS question papers → MPMSU question papers → WBUHS question papers → VNSGU question papers →